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Abstract 
 Many prepubertal girls and young women suffer from premature ovarian insufficiency 
induced by chemotherapy given for treatment of cancer and autoimmune diseases. Auto-
transplantation of cryopreserved ovarian tissue could restore the lost ovarian endocrine function 
and fertility. Unfortunately, tissue ischemia, inconsistent graft quality and the risk of re-
introducing malignant cells may stand in the way of the clinical translation of this approach. 
Therefore, isolation and re-implantation of multiple follicles may serve as a safer alternative; 
individual follicles can be isolated from the stromal environment in the ovarian tissue, and 
encapsulated in a hydrogel functioning as a supportive matrix for these isolated follicles. In the 
present study, we engineered an artificial ovarian tissue from the early stage follicles using a 
synthetic hydrogel, poly(ethylene glycol) vinyl-sulfone (PEG-VS), as a supportive matrix. The 
chemistry of the multi-arm PEG-VS formed by Michael-type addition allows: [1] modification 
with integrin binding peptides (such as RGD) for cell adhesion and migration and [2] a precise 
control over mechanical properties, making it suitable for reproductive tissue engineering 
applications.  In this work, first we characterized the crosslinking kinetics of multi-arm PEG 
hydrogel. We investigated the role of PEG functionality on bioactive modification and 
mechanical properties of hydrogels, and the combined effect of mechano-biological properties on 
behavior of encapsulated cells. While the molar concentration of the reactive functional groups 
was identical in all the conditions, PEG with a larger number of functional groups on each unit 
allowed a greater degree of modification as well as a more precise control of mechanical 
properties, making it more suitable for supporting three-dimensional culture. Next, we modeled 
premature ovarian failure in mice to analyze the capability of PEG hydrogels to support 
folliculogenesis, vascularization, steroidogenesis and graft longevity in vivo. PEG hydrogels 
 x 
 
supported folliculogenesis of enzymatically-isolated follicles, leading to repeating estrous cycles 
and functioning hypothalamus-pituitary-gonadal axis with physiological levels of follicle-
stimulating hormone. Furthermore, we demonstrated re-vascularization of the hydrogel, 
suggesting its capability of undergoing remodeling process. In summary, this is the first study 
proving the concept of a fully functional artificial ovarian tissue transplant built on the platform 
of the synthetic PEG hydrogel. 
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CHAPTER I 
 
 
Introduction 
 
 
1.1 Understanding ovarian physiology 
Ovarian tissue contains follicles at different developmental stages surrounded by stroma 
cells and rich vasculature. Follicles, the functional units of the ovary, are composed of a germ 
cell (the oocyte) and one or more layers of somatic cells (granulosa and theca cells), which are 
responsible for the production and metabolism of sex hormones, estradiol and progesterone. At 
birth, the human ovary contains approximately one million of immature follicles, called 
primordial follicles, which have the potential to develop and produce mature oocytes capable of 
fertilization. This number decreases to 300,000 follicles at puberty and continues to decline until 
menopause(1). The ovarian reserve declines rapidly with significantly decreasing fertility around 
the age of 38 in women due to follicle exhaustion, and eventually, leading to menopause. 
Premature depletion of the ovarian reserve in women exposed to chemotherapy causes premature 
ovarian failure (POF) and sterility.  
Primordial follicles, the most immature and abundant class of follicles, constitute the ovarian 
reserve, and activation of a small portion of this reserve each cycle ensures ovarian function(1). 
Mammalian females are born with a set number of immature primordial follicles, which remain 
quiescent until puberty. Starting at puberty during each menstrual cycle a small cohort of 
primordial follicles gets activated and enters the pool of growing follicles(2). Upon activation, at 
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the primary stage of development, the oocyte expands and granulosa cells become cuboidal(3). 
Through the secondary stage of development, the granulosa cells proliferate rapidly along with 
the somatic theca cells on the exterior basement membrane and secrete sex hormones in response 
to circulating gonadotropins. The process of the selection and maturation of follicles depends on 
a complex set of systemic and local signals exchanged between follicles and the surrounding 
environment, which include circulating hormones(4), paracrine factors(5), extracellular matrix(6, 
7), and vasculature(8-10). The final stage of follicle development into antral follicle culminates 
with the development of an antrum (a fluid-filled cavity adjacent to the oocyte), and it is 
followed by ovulation of an oocyte. 
 
 
 
 
Fig. 1.1 – Ovarian Physiology. Ovary contains follicles at different developmental stages surrounded 
by stroma cells and rich vasculature. Follicles, the functional units of the ovary, are composed of a 
germ cell (the oocyte) and layers of somatic cells (granulosa and theca cells), which are responsible 
for the production and metabolism of sex hormones, estradiol and progesterone. Copyright at 
Benjamin Cummings. 
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1.2 Fertility and ovarian endocrine function preservation 
Progress in modern anticancer therapy has led to improved long-term survival rates of above 
80% in most childhood malignancies(11). Unfortunately, chemotherapy and radiation have 
irreversible long-term side effects. Elimination of germline cells in the ovary and testes and 
resulting deficient reproductive and endocrine function is one of them. The rates of POF are very 
high; it occurs in up to 40% of the young women and girls treated with radiation and 
chemotherapy or combination of both(12, 13). In girls, POF has devastating consequences 
including late puberty, short stature and altered body image, interference with the physical and 
psychological development well into young adulthood(14). In young women, POF leads to a 
plethora of metabolic abnormalities; cripples cardiovascular system and causes premature 
aging(15, 16).  
Currently, clinical strategies for fertility preservation exist only for women who can produce 
a fully mature egg. If the anticancer treatment can be delayed, patients can undergo hormonal 
induction for 2 to 3 weeks to stimulate follicle development and recover mature oocytes(17). The 
oocytes can then be fertilized in vitro post-treatment. However, pre-treatment egg preservation 
does not address the loss of ovarian endocrine function, and most importantly, egg preservation 
is not available to prepubescent girls or patients who require immediate treatment(18). 
 In vitro follicle culture and cryopreservation of ovarian tissue could address the loss of 
fertility and endocrine function, and expand options available to the patients (Fig.1.2). Multiple 
reports have shown successful survival and growth of mature mouse follicles in vitro using either 
two- or three-dimensional culture systems(19-23), yet this approach can not address the loss of 
the endocrine function. Another technique is autotransplantation, which is transplantation of 
cryopreserved ovarian tissue, which has shown promising results for fertility and ovarian  
 4 
 
 
 
Fig.1.2 – Treatment Effects on Fertility and Options for Preserving Fertility in Women with 
Cancer. (A) A high-dose radiation and most chemotherapeutic agents damage the growing cells in 
mature and immature follicles and, depending on the type of drug, the dose, and the age of the patient, 
may result in depletion of many or all follicles. This depletion may result in a short-term loss of 
reproductive function and an inability to attain a natural pregnancy after treatment. (B) For patients 
who do not require immediate treatments, they can delay treatment and undergo hormonal induction 
for 2 to 3 weeks to stimulate follicle development and recover mature oocytes. The oocytes can be 
frozen or fertilized, depending on the wishes of the patient. If there is insufficient time or if there are 
contraindications, one ovary can be removed, and ovarian cortical strips can be cryopreserved for use 
in tissue transplantation or emerging techniques such as in vitro follicle maturation. (According to 
Jeruss, JS. and Woodruff, TK. Preservation of fertility in patients with cancer. N.Engl.J.Med. 2009, 
360, 9, 902 – 911.) 
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function restoration.  Autotransplantation does not require repeated cycles of hormone 
stimulation, thus reducing risk of ovarian carcinoma or ovarian hyperstimulation syndrome, and 
allowing immediate start of anti-cancer treatments(24). 
A successful autotransplantation would require maintenance of a large primordial follicle 
population, which can maintain monthly cycles and provide healthy fertilizable eggs(17, 25-27). 
However, several groups reported that the size of the graft decreased (30 – 70% of the original 
size) after autotransplantation, and there was a significant loss of the follicular pool (50 – 90%) 
due to tissue ischemia and hypoxia as a result of oxidative stress(28-30). Furthermore, it was 
hypothesized that insufficient number of follicles secreting inhibitory factors led to a burst 
activation of premature follicles and shortened graft longevity(31). As a result, multiple invasive 
procedures are required to achieve ovarian function due to the short life span of ovarian 
tissue(28). More importantly, the elevated risk of re-introducing malignant cells when 
transplanting ovarian tissue from a patient with hematological cancer presents another 
limitation(32). Therefore, isolating individual follicles free from other ovarian cells and grafting 
a purified follicle population presents a safer alternative; individual follicles can be separated 
from the rest the ovarian tissue, while the artificial supportive matrix can prevent follicular loss 
and promote graft remodeling. 
 
1.3 Tunable synthetic hydrogel as a platform for grafting of isolated follicles  
The chemistry of the multi-arm PEG-VS cross-linked by MTA allows: [1] modification with 
integrin binding peptides (such as RGD) for cell adhesion and migration(33, 34), and [2] a 
precise control over mechanical properties(35). Also stepwise co-polymerization of end-
functionalized multi-arm PEG-VS can be carried out at physiological temperature and pH(36), 
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making it suitable for reproductive tissue engineering applications. Multi-arm PEG hydrogels 
crosslinked with protease-sensitive peptides can degrade in response to enzymes secreted by the 
follicle, such as plasminogen activators (PA) and matrix metalloproteinases (MMPs) (Fig.1.3)(7, 
37-39). 
 
Cell and follicle responsive proteolytic degradation is required for cell proliferation, 
migration, and expansion of the follicle encapsulated in a hydrogel.  The mesh size of PEG 
hydrogels is in the range of tens to a hundred nanometers, which allows diffusion of oxygen and 
nutrients to the encapsulated tissues(40). Previous studies demonstrated that PEG-based matrices 
support folliculogenesis in vitro(22), vascularization of tissue constructs in vivo(41) and promote 
 
Fig. 1.3 – Synthesis scheme for the stepwise copolymerization of biomolecules containing free 
thiols on Cys residues with end-functionalized PEG macromers bearing conjugated 
unsaturated moieties. (Adapted to Lutolf, MP. et al. Synthesis and physiochemical 
characterization of end-linked poly(ethylene glycol)-co-peptide hydrogels formed by Michael-type 
addition. Biomacromolecules. (2003) 4,713 –722.) 
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matrix remodeling in bone defects(42, 43) through the control of the hydrogel degradation 
kinetics and their material properties. 
Therefore, we hypothesized that a finely tuned and functional PEG hydrogel would serve as a 
biomimetic grafting material that supports folliculogenesis, remodeling and vascularization. 
These tunable biophysical and biochemical properties(35, 36) of PEG hydrogels would 
successfully mimic the native complexity of the extracellular matrix and function as a platform 
for artificial ovarian tissues. 
 
1.4 Dissertation organization 
The aims of this doctoral research are to develop, validate, and characterize functional and 
tunable 3D synthetic PEG hydrogel to mimic the components of extracellular matrix (ECM) for 
reproductive tissue engineering applications. This study was designed to understand the role of 
biomimetic 3D hydrogels in reconstruction and regeneration of ovarian tissues in vivo. In 
Chapter II, we address three different components of building an artificial ovarian tissue from 
enzymatic isolation and purification of the early stage follicles to encapsulation in natural 
hydrogels. The work investigating the enzymatic isolation and purification of isolated follicles 
using microfluidic device was published in RSC Advances in 2013. Chapter III presents the work 
of characterizing natural hydrogels, fibrin, collagen or fibrin-collagen, to design more dynamic 
environment for cells, and to understand how different mechanical and biological properties 
affect cellular growth and behavior. This work was published in Journal of Biomedical Materials 
Research Part A in 2015. Chapter IV reports the work of characterizing of a synthetic PEG 
hydrogel: [1] how increasing PEG functionality from 4 to 8, and the act of bioactive modification 
affect the kinetics of hydrogel formation and material properties, [2] the combined effect of 
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mechano-biological properties on cellular behavior. This work was published in Soft Matter in 
2016. Chapter V describes the development of immature follicles encapsulated in PEG hydrogels 
and evaluates the graft function after orthotopic transplantation into ovariectomized mice. We 
demonstrated that PEG hydrogels with proteolytically-controlled degradation successfully 
supported follicle growth and promoted graft revascularization and remodeling. Regenerated 
artificial ovarian tissue successfully restored the cyclic hormonal changes in the reproductive 
tract as well as the function of Hypothalamus-Pituitary-Gonadal (HPG) axis. This work is 
currently under review. Lastly, chapter VI provides a summary of the findings and the future 
directions of this research in particular and the field in general. 
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CHAPTER II 
 
 
A first step toward building an artificial ovarian tissue – 
follicle isolation, purification and encapsulation  
 
 
2.1 Introduction 
Autotransplantation of ovarian tissue has shown promising results for fertility and ovarian 
function restoration, resulting in 60 live human births reported since 2004(1). Following ovarian 
tissue transplantation, patients resume menstrual cycles and can conceive naturally. The 
transplanted tissues vary in size, follicle numbers and efficiency of revascularization, which 
contributes to a number of limitations, such as premature follicle activation, burnout and graft 
failure. Yet, the greatest limitation of autotransplantation of ovarian tissue is the potential risks of 
re-introducing malignant cells when transplanting ovarian tissue from a patient with 
hematological cancers(2). Therefore, isolating and grafting a purified population of ovarian 
follicles presents a safer alternative to autotransplantation of ovarian tissue removed from a 
patient before the treatments. Enzymatic isolation serves as a gentle tool for harvesting a large 
population of the early stage follicles. Yet, the survival and function of the enzymatically 
harvested follicles is inadequate without the support from stromal cells and native extracellular 
matrix. 
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To provide three-dimensional (3D) support of these isolated follicles, naturally derived 
hydrogels can be used to preserve oocyte-somatic cell connections and the overall architecture of 
encapsulated follicles while enabling follicular expansion through degradation. They provide a 
3D environment similar to soft tissues, allow diffusion of nutrients, present critical biological 
signals, and degrade via endogenous enzymatic mechanisms(3). 
Natural hydrogels, such as fibrin and collagen, provide a biophysical and biochemical 
environment and allow interaction among embedded cells due to their endogenous biological 
activity. Fibrin gel, which is the main component in blood clots, has been characterized 
extensively as a plausible 3D hydrogel for various tissue-engineering applications(4, 5). Cell and 
follicle secreted enzymes, such as plasmin and matrix metalloproteinases (MMPs), can degrade 
fibrin, and allow cell migration and proliferation(6), making suitable for in vitro follicle culture.  
However, the survival rate of cultured primordial follicles, the most immature and abundant 
class of follicles in the ovary, is very low in vitro. Therefore, several groups have investigated an 
approach of grafting enzymatically-isolated immature follicles encapsulated in naturally derived 
hydrogels, such as alginate(13), fibrin(10-12), vascular endothelial growth factor (VEGF) 
releasing fibrin(9, 12), for delivery of isolated follicles and demonstrated complete 
folliculogenesis showing the potential of this approach in vivo(7-12). 
In this chapter, we addressed three different components of building an artificial ovarian 
tissue, from enzymatic isolation and purification of the early stage follicles to encapsulation in 
fibrin hydrogels. The viability and quality of the early stage follicles isolated using a cocktail of 
digestive enzymes, Liberase DH, and how these follicles were separated from stromal and cancer 
cells using microfluidic device are shown. We further discussed the previous studies of using 
fibrin hydrogels for grafting and their limitations for the design of artificial ovarian tissue.  
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2.2 Enzymatic isolation of the early stage follicles 
Enzymatic digestion allows isolation of primordial follicles from ovarian tissue. Primordial 
follicles have the greatest potential to survive cryopreservation and transplantation(14) due to 
their relative small size (30μm) compared to activated follicles (80 – 500μm in mice). It has been 
shown that hundreds of viable primordial and primary follicles can be isolated from fresh and 
cryopreserved ovarian cortical biopsies from young women using enzyme treatment(15, 16). 
Primordial follicles have high cryotolerance, which makes them more attractive for both in vivo 
and in vitro culture. The survival rate of gametes during the cryopreservation and subsequent 
transplantation was improved by dissociating the tissue into individual cells before 
cryopreservation(17, 18). For example, 70 – 80% of the initial number of gametes present at the 
resting primordial stages was recovered by using slow freezing protocols(15, 19). However, 
collagenase type I and DNAse I can cause partial disaggregation and damages to the basement 
membrane due to its high endotoxin levels(15, 20). 
 
 
Figure 2.1 - LIVE/DEAD staining of enzymatically isolated follicles using Liberase DH. To 
determine deleterious effects of isolation procedure on the viability of enzymatically isolated follicle 
(A), double fluorescent labeling LIVE/DEAD Cell Imaging Kit (Invitrogen) was performed. The 
enzymatically isolated follicle’s viability was confirmed by high Calcien AM (Green) staining (B). 
(According to Kim J et al. Synthetic hydrogel supports the function and regeneration of artificial 
ovarian tissue in mice. Unpublished Data.) 
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To address the limitations of collagenase type I, a purified blend of digestive enzymes, 
Liberase DH, was implemented to improve the quality of enzymatic isolation (Fig. 2.1)(21). 
Compared to collagenase, Liberase DH allowed isolation of a higher percentage of viable 
follicles with good morphology(22, 23). Overall, the isolation process can disrupt the oocyte-
follicular cell interface and lead to dispersion of granulosa or theca cells, causing detachment of 
oocytes(22, 24), which requires optimization of the follicle isolation protocol. However, there 
was no noticeable difference in oocyte maturation and embryo development rates between 
enzymatically and mechanically isolated follicles(25), and the connections between oocytes and 
somatic cells were reformed when enzymatically isolated follicles were encapsulated within 
three-dimensional gels(18, 26), supporting the idea of encapsulating within hydrogels. 
 
2.3 Purification of enzymatically isolated follicles using microfluidics 
Ovarian tissue can be removed prior to the whole body exposure to toxic chemotherapy, 
cryopreserved and later transplanted back to the patient to restore fertility. The major drawback 
of the tissue autotransplantation is the potential risk of reintroduction of cancer cells back to the 
patient. Ovarian follicles can be mechanically or enzymatically isolated from other cell types and 
transplanted back into the patient as a pure population of the reproductive units using current 
tissue engineering techniques. Smith, RM et al. and Kniazeva, E. et al. showed cell-size based 
separation of different cell types followed by enzymatic follicle isolation poses a potential 
application in the field of fertility preservation in cancer survivors, but did not completely 
removed stromal and cancer cells (Fig. 2.2)(10, 12). Soares et al. recently showed an approach of 
simple rinsing of the human follicles to remove leukemic cells(27); however, this method 
required manual pick up of isolated follicles. While purification of enzymatically isolated 
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follicles showed a promise of reducing residual cancer cells, further development of the isolation 
and purification is needed to eliminate cancer cells more effectively and efficiently.  
 
To effectively and efficiently remove residing cancer cells within the ovarian tissue, we used 
pseudo-grayscale (pGS) photomasks in combination with backside diffused light lithography 
(BDLL) to create a mold with a wide structure for soft lithography to produce a PDMS device 
with increased separation capacity to isolate the large ovarian follicles from the smaller cancer 
cells(28). Our design was effective at sorting of follicles from stromal and cancer cells. In these 
trials, 88% of the cancer cells were removed while 84% of ovarian follicles were recovered, as 
shown from examination of cell mixture before and after sorting by a microfluidic device (Fig. 
2.3). Our experimental observations suggest a fraction of cancer cells failed to be isolated from 
follicles due to the cancer cells adhering to the leftover extracellular matrix around the follicles. 
More experimentation will reveal the collagenase and liberase activity for the optimum cancer 
cell removal. In a clinically relevant scenario, we anticipate that an 88% contaminant removal 
 
Figure 2.2 - Tumor Burden Evaluation within Unprocessed Ovary and Prepared 
Transplantation Bead. Cancerous ovarian tissue extracted from a mouse 28 days post-inoculation 
(phase contrast in (a)) is showing a strong red fluorescent signal (b); (c) flow cytometry results for 
TdTomato+ MD-MBA-231BR cells within unprocessed ovary and transplant bead made from 
processed ovary, where tissue was extracted 5 days postinoculation; data shown represent average 
cell number± s.e.m., n= 5 and p= 0.03 by two-tailed Student’s t-test, * indicates statistical 
significance, where p≤ 0.05. (According to Kniazeva, E. et al. Primordial follicle transplantation 
within designer biomaterial grafts produce live birth in a mouse infertility model. Scientific Report. 
(2015) 5, 17709.) 
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may be enough to eliminate all cancer cells. This study would serve as future potential 
applications of clinical treatment-scale separation of ovarian follicles from cancer cells. 
 
 
 
 
 
Fig. 2.3 - Follicle sorting from GFP-MDA-MB-231 cancer cells. To further demonstrate the range of 
possible channel heights and their applications, a separate larger PDMS weir-type trap was produced 
with unspun SU-8 molds using pGS BDLL. Scale bar: 500 mm. a) Multi-layered microfluidic 
channels. b) Cancer cells were added into a solution containing primordial follicles within a petri dish. 
c) Follicles are trapped by weir-type traps while undigested collagen matrix squeezes through and 
cancer cells freely pass through. Flow was passive driven by a 7 cm height differential via suction of 
the outlet. d) The trapped follicles can be extracted from the device onto another petri dish by 
reversing the height differential of the inlet/outlet after a short flushing period with culture medium. 
The efficiency of cancer cell elimination is 88% and follicle recovery is 84%. (According to Lai, D. et 
al. Simple multi-level microchannel fabrication by pseudo-grayscale backside diffused light 
lithography. RSC Adv. (2013) 3, 19467.) 
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2.4 Grafting of isolated follicles using fibrin hydrogels 
 
Implantation of individually isolated follicles reduces the risk of re-implanting malignant 
cells, but it lacks the stromal support, which is the essential component for follicle survival and 
development. Isolated follicles need to maintain their 3D structure in order to prevent disruption 
of the metabolic link between granulosa cells (GCs) and oocytes, which are directly related to 
growth and survival(29). Therefore, naturally derived biomaterials, such as alginate(30), 
collagen(31) and fibrin(32, 33), have been employed to provide a temporary support due to their 
intrinsic biological activity, three-dimensionality, and biodegradability. These 3D grafts can 
function as a bridge between the host and the transplanted follicles and also as a supportive 
matrix for follicle development and cell infiltration to initiate the graft remodeling (Fig.2.4)(9). 
 
Fig. 2.4 – Schematic presentation of the hypothesis: (a) ovarian tissue transplanted in the bursal 
cavity lack the spatial connection to the host; (b) ovarian tissue encapsulation in degradable fibrin 
allows physical connectivity that may result in improved communication between the host and the 
graft and serve a continuous path for cell infiltration; (c) additionally to the described advantages of 
(b) controlled release of VEGF promoted revascularization. (According to Shikanov, A. et al. Fibrin 
encapsulation and vascular endothelial growth factor delivery promotes ovarian graft survival in 
mice. Tissue Eng. Part.A. (2011)17, 3095 – 3104) 
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Alginate hydrogels support follicle growth and 3D culture of rodent follicles. However, the non-
degradable nature of the alginate hydrogel was prohibitive in supporting the complete 
development of a human follicle, which typically reaches a diameter of 20 mm at the final stages 
of growth(34). On the other hand, fibrin has been extensively investigated as a grafting material 
for isolated follicles, because it can degrade in response to enzymes secreted by the follicle such 
as plasminogen activators (PA) and matrix metalloproteinases (MMPs)(35). 
 
Multiple previous studies successfully demonstrated the use of fibrin hydrogels for the 
transplantation of ovarian tissue or isolated ovarian follicles, resulting in complete follicular 
development(9-12). Smith, RM. et al. reported successful development of transplanted early-
stage follicles into fully-grown antral follicles during 21 days in vivo. However, fibrin failed to 
support longer graft function due  to significant reduction in follicle pool as a result of matrix 
degradation(10) and poor support of the graft structure(36) (Fig.2.5). Shikanov, A. et al.(9) and 
Kniazeva, E. et al.(12) demonstrated extended longevity and function by incorporating vascular 
endothelial growth factor (VEGF) (Fig.2.4). The controlled release of VEGF initiated functional 
vascularization promoting follicle survival(9). These studies showed the potential of grafting of 
 
Fig. 2.5 – Follicle development and attrition in fibrin. (A) Number of follicles as a function of 
time in the graft during 21 days post-transplantation. Different letters above bars indicate significant 
differences (p < 0.05). (B) Percentage of follicles in each developmental stage within the graft (n = 
6, 6, 10, and 12 for day 0, 3, 9, and 21, respectively) (Adapted from Smith, RM. et al. Fibrin-
mediated delivery of an ovarian follicle pool in a mouse model of infertility. Tissue Eng. Part.A. 
(2014) 20(21), 3021 – 3029) 
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isolated follicles for delivery in vivo. However, the poor control of physical properties of 
naturally derived biomaterials, such as degradation rate and matrix stiffness, and lot-to-lot 
compositional and structural variability(37, 38) limits their applications and clinical translations. 
 
2.5 Conclusion 
In summary, we addressed three different components toward building an artificial ovary, 
from enzymatic isolation and purification of the early stage follicles to encapsulation in natural 
hydrogels. The large populations of early stage follicles isolated and encapsulated were viable, 
which were separated from stromal and cancer cells using microfluidic device with high 
efficiency. Follicle sorting using microfluidic device would serve as future potential applications 
of clinical treatment-scale separation of ovarian follicles from cancer cells. Encapsulating 
isolated follicles in fibrin hydrogels has shown promising results; however, the rapid degradation 
and coupled mechanical and biological properties of fibrin hydrogels resulted in early graft 
failure, limiting their long-term applications. This result further confirmed the importance of 
dynamic hydrogel design for reproductive tissue engineering applications. 
 
2.6 Materials and methods 
2.6.1. Enzymatic follicle isolation and viability assessment 
For all experiments, ovaries were isolated from 6 or 7-day-old female mice (F1 CBA/J x 
C57BL/6N), separated from the connective tissues and enzymatically digested in 50 μL (13 
Wünsch units/mL) Liberase DH (Roche, Indianapolis, IN) in 500 μL L15 (Leibovitz’s) media 
(Sigma-Aldirch) (Fig.2.1B). The total digestion time was 50min at 37 
o
C, followed by 20min 
gentle pipetting of enzyme-digested pieces. The enzyme digestion was arrested by adding 10% 
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fetal bovine serum and the digest was transferred to a tube for sedimentation. The sedimentation 
velocity of primordial and primary follicles was calculated according to a previously published 
report(10). After 15 min of sedimentation, the top half of the total media containing slower 
sinking arbitrary cells was removed. The rest of the media volume remaining follicular 
suspension was removed by centrifuging at 100G for 5min. To determine any deleterious effecst 
of the isolation procedure on the viability of enzymatically isolated follicles, double fluorescent 
labeling LIVE/DEAD Cell Imaging Kit (Invitrogen) was performed according to the 
manufacturer’s protocol. 
2.6.2. Follicle sorting using pseudo-grayscale (pGS) photomasks in combination with backside 
diffused light lithography (BDLL)(28)  
Devices were fabricated using pGS BDLL with channel heights of 58 mm and weir-type 
traps of 21 to 8 mm in height for blood sorters and channel heights of 120 mm and 20 mm traps 
for the follicle sorters. Five thousand MDA-MB-231 human breast cancer cells (5 µL of 10
6
   
mL
-1
 suspension) were added to the follicle-stromal cell suspension to mimic the scenario of 
cancer cell contaminated tissue. A dramatically higher amount of cancer cells than what is 
clinically expected was used to facilitate calculation of isolation efficiency. Cells and follicles 
were sorted using multi-level channels to produce weir-type traps. 
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CHAPTER III 
 
 
Characterizing natural hydrogels - towards more dynamic 
hydrogel design 
 
 
3.1 Introduction 
The extracellular matrix (ECM) provides the three-dimensional structure and paracrine 
signals that regulate and promote cell adhesion and directs the cellular processes leading to tissue 
development(1, 2). ECM also affects morphology(3), cell communication(4, 5), survival(6, 7), 
proliferation(8) and steroidogenesis(9). In vivo, cells are embedded within a complex 
environment that contains multiple ECM components and cell-secreted factors(10). In addition to 
complexity, cell morphology and orientation with respect to matrix architecture can affect 
cellular response and their function(11). The ECM is a highly dynamic structure that undergoes 
continuous controlled remodeling, and in order to promote appropriate development, precise 
control and regulation of ECM assembly, modification and degradation are needed(12).  
Naturally derived materials mimicked some components of ECM, but they were still limited 
to modeling static environments compared to complex tissue processes. For example, in 
applications focused on supporting ovarian follicle in vitro, a hydrogel must accommodate the 
significant increase in follicle volume through degradation. The volumetric expansion of the 
growing follicle is approximately 300 folds in mice and about 10
5
 fold in humans(13, 14) along 
with massive recruitment of cells and vessels to support follicle development(15). Alginate 
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hydrogels restricted and compressed the expansion of a human follicle, which typically reaches a 
diameter of 20mm(16), beyond 700μm due to the non-degradability of the hydrogel. This proves 
that the degradation and elasticity of the matrix are important factors to accommodate the follicle 
growth. 
Therefore, Shikanov, A et al. investigated the fibrin-alginate interpenetrating networks (FA-
IPN), which combined the degradable and non-degradable components, to provide more 
dynamic cell-responsive hydrogel design to culture follicles in vitro(17). Alginate provided the 
physical support while fibrin degraded to create a space for follicle growth and expansion. The 
fibrin degradation rate was also controlled by using a monomeric serine protease inhibitor, 
aprotinin, which extended the period of follicle culture and mechanical integrity in vitro(18).  
In this chapter, to further explore how different mechanical properties and degradation rate of 
natural hydrogels affect cellular phenotype and behavior, we encapsulated human bone marrow 
derived stromal cells (HS-5) in fibrin, collagen or fibrin-collagen hydrogels. We explored 
different concentrations of aprotinin to the culturing media to control the fibrin degradation rate 
and to extend the period when the stromal network architecture is supported. The fast 
degradation rate of fibrin was controlled with aprotinin; however, high concentration of aprotinin 
slowed down fibrinolysis significantly, which slowed down cell growth as well. Among the 
different gel systems, more cell growth and more interconnected stromal network formation were 
observed when cells were in less rigid and more degradable environments, allowing branching 
and cell remodeling. This study further discusses how the kinetics of fibrin degradation and 
stiffness significantly affected cell proliferation, migration and cell-mediated matrix remodeling. 
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3.2  Results 
3.2.1 Stromal network formation in fibrin gel 
To design a 3D hydrogel system that can support and mimic a lymphoid stromal network, 
fibrin gel was investigated. The encapsulated HS-5 cells in fibrin gel (6 mg/mL) demonstrated 
fibroblast-like spindle morphology at Day 2, and stromal networks began to form through 
branching and joining with other adjacent cell populations by Day 6 (Fig.3.1A). However, due to 
the rapid fibrinolysis along with cell growth, fibrin degraded completely by Day 8, leading to the 
loss of the structural support and contraction of the stromal network architecture (Fig.3.1A). 
Inability to maintain the matrix architecture after complete network formation restricted T-cell 
penetration into the network due to the high density of the cells and the collapse of the fibrin 
structure. 
3.2.2  Optimal aprotinin concentration controls fibrin degradation and cell spreading  
We hypothesized that the kinetics of fibrin degradation would affect cell proliferation, 
migration and cell-mediated matrix remodeling. We used a monomeric serine protease inhibitor, 
aprotinin, added to the culturing media to control the fibrin degradation rate and to extend the 
period when the stromal network architecture is supported. Higher concentration of aprotinin 
(0.1 TIU/mL) slowed down fibrinolysis significantly (Fig.3.1B, 3.1C), but also restricted cell 
growth (Fig.3.1A). As a result, we concluded that in order for HS-5 cells to proliferate and 
connect with other surrounding cells, these cells have to be able to migrate and remodel their 
microenvironment. Reducing the aprotinin concentration to 0.05 TIU/mL resulted in sufficient 
cell proliferation for network formation, and slow enough fibrin degradation (Fig.3.1A). 
 28 
 
 
 
Figure 3.1. Effects of aprotinin on HS-5 stromal network formation and fibrin degradation rate. (A) HS-5 
cells encapsulated in fibrin (6 mg/mL) gel [220,000 cells/ml gels] and two different concentrations of aprotinin 
(0.1 TIU/mL and 0.05 TIU/mL) were supplemented with media. Scale Bar: White = 200 μm, Black = 500 μm (B) 
GFP labeled HS-5 were encapsulated in fibrin gels copolymerized with 2% w/w AlexaFluor 546 (558/573 nm) 
labeled fibrinogen to measure the fibrin degradation during the stromal network formation. Scale Bar: 200 μm (C) 
Fluorescence was measured in the media that was collected every 2 days from fibrin gels labeled with 2% w/w 
AlexaFluor 546. Stronger fluorescence was detected in media collected from more degraded fibrin gels, verifying 
the effect of aprotinin concentration on fibrinolysis. No autofluorescence was detected in the media. Values are 
reported as mean ± S.D. (n = 5) (D) The area occupied by cells was quantified as the area corresponding with GFP 
fluorescence within 100x images (Fig.S3). Only fibrin gel supplemented with aprotinin (0.05 TIU/mL) showed 
significant increase in normalized fluorescent cell area from day 4 to day 8. However, there was statistical 
difference only between fibrin gel with 0.05 TIU/mL aprotinin and fibrin gel with 0.1 TIU/mL aprotinin at day 8 
throughout the culture. Values are reported as mean ± S.D. (n = 5). Significance was determined by a Two-way 
ANOVA followed by Tukey post-tests (*,**,# p <0.05). 
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After identifying the optimal aprotinin concentration that allows both control over 
fibrinolysis and maintenance of the stromal network, the ability to support cell growth and 
network formation was assessed quantitatively by measuring the fluorescent area occupied by the 
cells in the hydrogel (Fig.3.1D). Compared to no-aprotinin control condition, fibrin gels 
supplemented with aprotinin (0.05 TIU/mL) showed slower cell proliferation rate and lower cell 
area in the beginning stage of culture, which then significantly increased, by Day 8 (Fig.3.1D). 
On the other hand, the cell area in fibrin gel without aprotinin slightly decreased at Day 8 due to 
accelerated fibrinolysis and its inability to maintain the architecture leading to the collapse of the 
stromal network (Fig.3.1D). Only fibrin gel supplemented with aprotinin (0.05 TIU/mL) showed 
significant increase in normalized fluorescent cell area from day 4 to day 8, proving the 
importance of a balance between fibrin degradation and cell proliferation in the stromal network 
formation (Fig.3.1D). There was no statistical difference in normalized cell area between fibrin 
gel supplemented with 0.05 TIU/mL aprotinin and fibrin gel alone throughout any day of the 
culture; however, the ability to maintain the structural architecture after complete network 
formation was significantly improved with the addition of 0.05 TIU/mL aprotinin (Fig.3.1A). 
3.2.3  Comparison between three different hydrogel systems: fibrin, fibrin-collagen, and 
collagen 
Based on results from the aprotinin test with fibrin gels, we hypothesized that combining the 
faster degrading fibrin and slow degrading collagen gel would provide optimal degradation rate 
and structural rigidity to promote cell growth and network formation. Fibrin concentration was 
kept constant at 6 mg/mL and only collagen concentration was varied (Collagen concentration: 2 
mg/mL and 4 mg/mL) to identify the optimal concentration for HS-5 cells.  
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In general, both the degree of stromal network formation and the number of viable cells 
clearly increased with decreasing collagen concentration in collagen and fibrin-collagen gels. 
Fibrin gel supplemented with aprotinin (0.05 TIU/mL) showed significantly higher values of cell 
 
Figure 3.2. Comparison between three different hydrogel systems: Fibrin, Fibrin-Collagen, and Collagen. 
(A) GFP labeled HS-5 cells [220,000 cells/ml gels] encapsulated in six different hydrogel conditions: fibrin with 
and without aprotinin, fibrin-collagen, and pure collagen at various concentrations. Fibrin concentration was kept 
at 6 mg/mL for all gels and only collagen concentration was varied from 2 mg/mL to 4 mg/mL. HS-5 formed 
more interconnected and complete network in Fibrin gel with aprotinin (0.05 TIU/mL). Scale Bar: 200 μm. (B) 
The normalized fluorescent cell area was quantified as the area corresponding with the GFP fluorescence within 
100x images and compared between the different hydrogel systems. Fibrin gel supplemented with aprotinin 
(0.05 TIU/mL) showed significantly greater values of total cell area at day 8 compared to all compositions of 
collagen and fibrin-collagen. However, there was no statistical difference between fibrin gel supplemented with 
aprotinin and fibrin gel alone. (C) CellTiter-Glo Luminescent Cell Viability Assays was used to determine the 
total number of viable cells per gel based on quantification of ATP. Fibrin gel supplemented with aprotinin (0.05 
TIU/mL) showed significantly greater values of viable cells at Day 8 compared to collagen (4 mg/mL) and 
fibrin-collagen (4 mg/mL). There was no statistical difference between fibrin gel supplemented with aprotinin 
and fibrin gel alone in both cell area and viable cell number. Values are reported as mean ± S.D. (n = 5). 
Significance was determined by a Two-way ANOVA followed by Tukey post-tests. (* p < 0.05) 
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area (Fig.3.2B) as well as viable cell number (Fig.3.2C) at Day 8 compared to all concentrations 
of collagen and fibrin-collagen and supported 67-fold increase in the number of viable cells. This 
could be because compact environments restrict cell growth. There was no statistical difference 
between fibrin gel supplemented with aprotinin and fibrin gel alone in both normalized cell area 
and viable cell number; however, a dense mass of cells formed in fibrin gel without aprotinin 
(Fig.3.2A) due to the collapse of the fibrin structure.  
 
3.3 Discussion 
Natural hydrogels provide a 3D mechanical and biochemical environment and allow 
interaction among embedded cells due to their endogenous biological activity. Fibrin and 
collagen gels undergo cell-mediated degradation through cell-secreted enzymes, such as plasmin 
and matrix metalloproteinase (MMPs) allowing cell migration, proliferation and remodeling of 
the encapsulating matrix(19). We have characterized each hydrogel system and its ability to 
support the 3D stromal network formation. Among the different gel systems, more cell growth 
and more interconnected stromal network formation were observed when cells were in less rigid 
and more degradable environments, allowing branching and cell remodeling. The fast 
degradation rate of fibrin can be controlled with aprotinin, making it a potential material for in 
vitro 3D hydrogel system. High concentration of aprotinin slowed down fibrinolysis 
significantly; however, it slowed down cell growth as well. In order for cells to proliferate and 
connect with other surrounding cells, these cells have to be in a microenvironment where they 
can migrate and remodel. After reducing the aprotinin concentration to 0.05 TIU/mL, the level of 
proliferation and network formation were recovered while slowing down the fibrin degradation.  
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To better mimic the in vivo microenvironment, we further investigated fibrin-collagen by 
incorporating naturally degradable fibrin into collagen gel to allow more cell growth and better 
stromal network support. Surprisingly, fibrin-collagen showed lower values of normalized 
fluorescent cell area and viable cell number compared to both pure fibrin and collagen. This 
could be due to the overall mechanics of fibrin-collagen and collagen gels being influenced by 
changes in the network architecture. Multiple studies have shown the trend of increase in the 
stiffness of fibrin-collagen compared to that of pure fibrin or collagen gel(20-22). Depending on 
protein concentrations, the storage modulus of the gel varied; however, the trend of fibrin-
collagen having a greater modulus compared to pure fibrin or collagen was consistent throughout 
these studies. The increase in the microstructure stiffness is likely due to the greater amount of 
protein in fibrin-collagen gels and the combinatory effect of highly connected bundles of 
collagen and inter-fibrillar bonding of fibrin(21, 23). Also it has been shown that the 
permeability correlates with the overall collagen content and decrease in the collagen resulted in 
an increase in overall permeability(24). 
Gel contraction of both collagen and fibrin-collagen gels over time also could have restricted 
stromal cell growth and network formation. Collagen-containing gels are known to contract over 
time due to cells attaching and pulling on fibers as well as the force generated from cell-to-cell 
contact(25, 26). Fibrin-collagen underwent more significant contraction compared to pure 
collagen gels as fibrin degraded away. Fibrin gel also contracts, but the addition of optimal 
aprotonin concentration resulted in balanced matrix degradation and cell proliferation, making it 
more suitable for three dimensional cell culture and tissue engineering applications. 
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3.4  Conclusion 
Throughout the different gel systems, more cell growth and more interconnected stromal 
network formation were observed when cells were in less rigid and more degradable 
environments, which allowed branching and cell-driven remodeling. Unlike slow degrading 
collagen-containing gel systems, fibrin degradation rate can be controlled with aprotinin, which 
allows better control of microenvironment. We further investigated fibrin-collagen by 
incorporating naturally degradable fibrin into collagen gel to allow both degradation and 
structural support; however, cellular growths in fibrin-collagen gels were more restricted due to 
higher stiffness. These results demonstrated the importance of controlled degradation rate and 
the stiffness, which affects the cellular capabilities to remodel their surrounding environment. 
Controlling the degradation rate of fibrin hydrogel using aprotinin was successful in both 3D cell 
and follicle cultures and extended the period of culture; however, this approach is only 
applicable for in vitro systems. Our findings further confirmed the importance of a precise and 
local control of hydrogel properties, such as degradation kinetics and stiffness, to design the 
optimum environment for cells as well as ovarian follicles, increasing the needs of synthetic 
hydrogels with tunable properties. 
 
3.5 Materials and methods 
3.5.1 Cell isolation and culture 
Human bone marrow stromal cell lines, HS-5 (ATCC CRL-11882) were cultured in DMEM 
(Dulbecco’s modified Eagle’s medium) culture medium (ATCC) supplemented with 10% fetal 
heat inactivated bovine serum (FBS) (Biowest). HS-5 cells, which resemble FRCs in that they 
are podoplanin-positive and CD31-negative, were cultured in T-75 flasks and split in a 1:5 ratio 
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every 3-4 days. CD4+ T cells used in this study, P2 cells(27), were isolated from A3.01 cells (a 
subclone of the CEM cell line) based on its high propensity to adopt a polarized shape. These T 
cells were cultured in RPMI-1640 medium (Gibco Life Technologies) supplemented with 10% 
heat inactivated FBS in T-25 flasks, placed upright, and split in a 1:10 ratio every 3-4 days. All 
culture media were supplemented with 1% PenStrep (Lonza) and incubated in 5% CO2 
atmosphere at 37°C. 
3.5.2 Gel preparation and cell encapsulation 
3.5.2.1 Fibrin gel 
Dialyzed sterile bovine fibrinogen (Sigma Aldrich) (12.0 mg/mL), HS-5 cells, and bovine 
thrombin (Sigma) (50 IU/mL) were mixed and extruded homogeneously using the extruder from 
the Hemaseel APRTM Sealer Protein Kit (Haemacure) to obtain a fibrin gel with the final 
fibrinogen of 6 mg/mL and 220,000 cells/mL gel concentrations. Fibrin gels (each with 200 μL 
volume) with encapsulated stromal cells were allowed to gel in 48 well plates for 10 min in the 
incubator (37°C, 5% CO2). Fibrin coagulated and formed solid gels after 10 min and the addition 
of 200 μL media did not disturb the morphology of the gel. A timeframe of 10 min was selected 
to maximize the cell viability during the polymerization process. Media was changed every 2 
days and cells were cultured up to 8 days. Each experiment was repeated five times and the 
results were reproducible. 
3.5.2.2 Type I collagen gel 
Type I Collagen rat tail (Col I) (8.56 mg/mL) (BD Biosciences) was mixed with the 
appropriate amounts of 10x PBS, 1N NaOH and dH2O to make the final concentration of 2 
mg/mL or 4 mg/mL. This was quickly followed by the addition of cells to reach a final 
concentration of 220,000 cells/mL. Constructs (each with 200 μL volume) were allowed to gel in 
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48 well plates for 10 min in the incubator (37°C, 5% CO2). Collagen coagulated and formed solid 
gels after 10 min and the addition of 200 μL media did not disturb the morphology of the gel. 
Media was changed every 2 days and cells were cultured up to 8 days. Each experiment was 
repeated five times and the results were reproducible. 
3.5.2.3 Fibrin-collagen I gel 
To reach a final concentration of 6 mg/mL fibrinogen and 2 mg/mL or 4 mg/mL Type I 
Collagen in a gel, we added the appropriate amounts of Col I (8.56 mg/mL), fibrinogen (12.0 
mg/mL), 10x PBS, 1N NaOH, dH2O and 50 IU/ml bovine Thrombin (Sigma). Each 
concentration of fibrinogen, thrombin, and collagen were selected based on previous in vitro 3D 
cell culture studies(20-22), which have shown to support cell growth and proliferation. Cells 
were harvested and resuspended in fibrinogen to reach a final concentration of 220,000 cells/mL. 
Constructs (each with 200 μL volume) were allowed to gel in 48 well plates for 10 min in the 
incubator (37°C, 5% CO2). Fibrin-collagen coagulated and formed solid gels after 10 min and the 
addition of 200 μL media did not disturb the morphology of the gel. Media was changed every 2 
days and cells were cultured up to 8 days. Each experiment was repeated five times and the result 
were reproducible. 
3.5.3 GFP transfection 
To visualize HS-5 stromal networks up to 8 days in culture and to quantify cell area using 
fluorescence, HS-5 cells were stably transfected to express green fluorescent protein (GFP). 24 
hours prior to transfection, HS-5 cells were seeded in 6-well plate to reach 60% confluency on 
the day of transfection. Plasmid DNA vector (pLenti-III-CMV-GFP-Puro, LV590, Applied 
Biological Materials) was mixed with Fugene 6 transfection reagent (Promega) and Opti-MEM® 
(Life Technologies) according to manufacturer’s instructions. DNA/Fugene6/Opti-MEM® 
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mixture was added dropwise to the well of 6-well plate containing growth medium. Cells were 
then incubated at 37°C for 48 hours. The GFP plasmid construct contains a puromycin resistance 
gene, which allows selecting stably transfected cells by culturing in a medium supplemented 
with 1 μg/ml puromcyin (Sigma-Aldrich). After 48 hours, incubated HS-5 cells were subcultured 
1:3 in selection medium. Selection medium were replaced every 3 days for 14 days. Successful 
selection was confirmed by the observation of 100% distinct colonies of surviving GFP-positive 
HS-5 cells. 
3.5.4 Fluorescent area measurement 
A MATLAB
®
 code was created using the Image Processing Toolbox in order to determine 
the approximate area of GFP expressing cells. Specifically, the green channel was parsed out 
from each image before using image segmentation functions to create a gradient picture. Image 
segmentation relies upon differences in contrast in order to create a binary mask of the image. 
Once the binary mask image contained outlines of the cells, the mask was dilated and filled in 
order to cover the full area of each cell. Within the binary mask, white spots denoted cells, and 
cell area was calculated by determining the number of white pixels per image and converting the 
number to a size in microns (Fig.3S1). Additionally, the binary mask outline was superimposed 
onto the original image to ensure that cell area was detected appropriately. All the analyzed 
images were taken at 100x magnification by the inverted microscope Leica DMI3000B and 
images were screened, selected and analyzed using a double-blind method (n = 5). 
3.5.5 Aprotinin test 
To slow down fibrinolysis, the culturing media (DMEM with 10% FBS) was supplemented 
with monomeric serine protease inhibitor, aprotinin (Sigma-Aldrich). Aprotinin was added in the 
medium to reach and to maintain sufficient concentration levels throughout the 8 days of culture 
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and to be able to easily modify the concentration if necessary. Before addition, 1 TIU/mL 
aprotinin was diluted with culturing media to the desired aprotinin concentration (0.1 TIU/mL 
and 0.05 TIU/mL). Aprotinin was added beginning on Day 2 and continued until Day 8 of 
culture. At Day 4, Day 6, and Day 8 of the culture, its effects on HS-5 stromal network formation 
were examined by measuring the fluorescent cell area as described previously (n = 5). 
3.5.6 Fibrin degradation assays 
To measure the degradation rate of fibrin gels, we mixed unlabeled fibrinogen with 
AlexaFluor546 conjugate (558/573 nm) labeled fibrinogen with (Invitrogen), resulting in 2% 
w/w labeling. HS-5 cells were encapsulated in the fluorescently labeled fibrin gels and cultured 
in DMEM without phenol red and supplemented with 4 mM L-Glutamine (ATCC). A plate 
reader (Fluoroskan Ascent FL) was used to measure the levels of soluble degradation products, 
AlexaFluor conjugate, released from the labeled fibrinogen as a result of the fibrin degradation 
(n = 5). Media was collected every 2 days for up to 8 days of culture. As a control, we measured 
the release of the AlexaFluor conjugate to the media from fibrin gels without cells to ensure that 
the fibrin degradation is driven by the cells. We did not detect fluorescent signal when fibrin gels 
were cultured without the cells and no autofluorescence was detected from the media. 
3.5.7 Stromal cell viability 
CellTiter-Glo Luminescent Cell Viability Assays (Promega) was used to determine the 
number of viable cells based on quantification of ATP present, which indicates the presence of 
metabolically active cells. This procedure was carried out on Day 8 for all conditions as 
described by the manufacturer’s protocol. The luminescence values were recorded by using a 
platereader (Fluoroskan Ascent FL) after 10 minutes of incubation at room temperature to 
stabilize the luminescent signals. Standard curves were generated for each gel condition to 
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identify the linear relationship between the luminescent signal and the number of cells in the 
hydrogel, ranging from 0 to 2 million cells per gel in the 96-well format (n = 5).  
3.5.8 Statistical analysis 
All statistical analyses were performed using GraphPad Prism (GraphPad Prism Software, La 
Jolla, CA). Data are reported as mean ± standard deviation of measurements, and analyzed with 
Two-way ANOVA followed by Tukey post-test. Statistical significance was assumed when p < 
0.05.  
3.6 References  
1. Giancotti FG, Ruoslahti E. Integrin signaling. Science. 1999 Aug 13; 285(5430): 1028-1032.  
2. De Arcangelis A, Georges-Labouesse E. Integrin and ECM functions: Roles in vertebrate 
development. Trends Genet. 2000 Sep; 16(9): 389-395.  
3. Ben-Ze'ev A, Amsterdam A. Regulation of cytoskeletal proteins involved in cell contact 
formation during differentiation of granulosa cells on extracellular matrix. Proc Natl Acad Sci U 
S A. 1986 May; 83(9): 2894-2898. PMCID: PMC323413.  
4. Albertini DF, Kravit NG. Isolation and biochemical characterization of ten-nanometer 
filaments from cultured ovarian granulosa cells. J Biol Chem. 1981 Mar 10; 256(5): 2484-2492.  
5. Anderson E, Albertini DF. Gap junctions between the oocyte and companion follicle cells in 
the mammalian ovary. J Cell Biol. 1976 Nov; 71(2): 680-686. PMCID: PMC2109751.  
6. Adams JC, Watt FM. Regulation of development and differentiation by the extracellular 
matrix. Development. 1993 Apr; 117(4): 1183-1198.  
7. Irving-Rodgers HF, Mussard ML, Kinder JE, Rodgers RJ. Composition and morphology of 
the follicular basal lamina during atresia of bovine antral follicles. Reproduction. 2002 Jan; 
123(1): 97-106.  
8. Rodgers HF, Irvine CM, van Wezel IL, Lavranos TC, Luck MR, Sado Y, Ninomiya Y, 
Rodgers RJ. Distribution of the alpha1 to alpha6 chains of type IV collagen in bovine follicles. 
Biol Reprod. 1998 Dec; 59(6): 1334-1341.  
9. Kreeger PK, Woodruff TK, Shea LD. Murine granulosa cell morphology and function are 
regulated by a synthetic arg-gly-asp matrix. Mol Cell Endocrinol. 2003 Jul 31; 205(1-2): 1-10.  
 39 
 
10. Baker BM, Chen CS. Deconstructing the third dimension: How 3D culture 
microenvironments alter cellular cues. J Cell Sci. 2012 Jul 1; 125(Pt 13): 3015-3024. PMCID: 
PMC3434846.  
11. Kurpinski K, Chu J, Hashi C, Li S. Anisotropic mechanosensing by mesenchymal stem cells. 
Proc Natl Acad Sci U S A. 2006 Oct 31; 103(44): 16095-16100. PMCID: PMC1637542.  
12. Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and 
disease. Nat Rev Mol Cell Biol. 2014 Dec; 15(12): 786-801. PMCID: PMC4316204.  
13. Picton HM. Activation of follicle development: The primordial follicle. Theriogenology. 
2001 Apr 1; 55(6): 1193-1210.  
14. Shikanov A, Smith RM, Xu M, Woodruff TK, Shea LD. Hydrogel network design using 
multifunctional macromers to coordinate tissue maturation in ovarian follicle culture. 
Biomaterials. 2011 Apr; 32(10): 2524-2531. PMCID: PMC3040241.  
15. Amorim CA. Artificial ovary. In: Donnez J, Kim S, editors. Principles and Practice of 
Fertility Preservation.. Cambridge, UK: Cambridge University press; 2011. p. 448-458.  
16. Gougeon A. Regulation of ovarian follicular development in primates: Facts and hypotheses. 
Endocr Rev. 1996 Apr; 17(2): 121-155.  
17. Shikanov A, Xu M, Woodruff TK, Shea LD. Interpenetrating fibrin-alginate matrices for in 
vitro ovarian follicle development. Biomaterials. 2009 Oct; 30(29): 5476-5485. PMCID: 
PMC2906124.  
18. Shikanov A, Xu M, Woodruff TK, Shea LD. A method for ovarian follicle encapsulation and 
culture in a proteolytically degradable 3 dimensional system. J Vis Exp. 2011 Mar 15; (49). pii: 
2695. doi(49): 10.3791/2695. PMCID: PMC3197327.  
19. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost. 2005 Aug; 
3(8): 1894-1904.  
20. Rao RR, Peterson AW, Ceccarelli J, Putnam AJ, Stegemann JP. Matrix composition 
regulates three-dimensional network formation by endothelial cells and mesenchymal stem cells 
in collagen/fibrin materials. Angiogenesis. 2012 Jun; 15(2): 253-264. PMCID: PMC3756314.  
21. Rowe SL, Stegemann JP. Interpenetrating collagen-fibrin composite matrices with varying 
protein contents and ratios. Biomacromolecules. 2006 Nov; 7(11): 2942-2948. PMCID: 
PMC1795649.  
22. Lai VK, Lake SP, Frey CR, Tranquillo RT, Barocas VH. Mechanical behavior of collagen-
fibrin co-gels reflects transition from series to parallel interactions with increasing collagen 
content. J Biomech Eng. 2012 Jan; 134(1): 011004. PMCID: PMC3717315.  
 40 
 
23. Lewis JL, Johnson SL, Oegema TR,Jr. Interfibrillar collagen bonding exists in matrix 
produced by chondrocytes in culture: Evidence by electron microscopy. Tissue Eng. 2002 Dec; 
8(6): 989-995.  
24. Helm CL, Zisch A, Swartz MA. Engineered blood and lymphatic capillaries in 3-D VEGF-
fibrin-collagen matrices with interstitial flow. Biotechnol Bioeng. 2007 Jan 1; 96(1): 167-176.  
25. McGuigan AP, Bruzewicz DA, Glavan A, Butte MJ, Whitesides GM. Cell encapsulation in 
sub-mm sized gel modules using replica molding. PLoS One. 2008 May 21; 3(5): e2258. PMCID: 
PMC2376064.  
26. Roy P, Petroll WM, Chuong CJ, Cavanagh HD, Jester JV. Effect of cell migration on the 
maintenance of tension on a collagen matrix. Ann Biomed Eng. 1999 Nov-Dec; 27(6): 721-730.  
27. Llewellyn GN, Hogue IB, Grover JR, Ono A. Nucleocapsid promotes localization of HIV-1 
gag to uropods that participate in virological synapses between T cells. PLoS Pathog. 2010 Oct 
28; 6(10): e1001167. PMCID: PMC2965768.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 41 
 
 
 
 
CHAPTER IV 
 
 
 
Characterization of the crosslinking kinetics of multi-arm 
poly(ethylene glycol) hydrogels formed via Michael-type 
addition 
 
 
4.1  INTRODUCTION 
Naturally derived and synthetic hydrogels have been extensively exploited in biomedical 
materials research due to their abilities in directing cellular behavior and function(1, 2).  Natural 
hydrogels, such as collagen(3) and fibrin(4), are compatible with live cells, support cell 
attachment, migration and remodeling; however, the mechanical and biological properties of 
these materials are closely tied. For example, altering the Matrigel or collagen concentration in 
hydrogels changes the stiffness of the gel and also affects the concentration of bioactive factors, 
such as integrin binding and protease sensitive sites. This interdependence of mechanical 
properties and the biological activity in natural hydrogels makes it challenging to prepare 
matrices suitable for the diverse requirements of biomedical applications. In contrast to natural 
hydrogels, biologically inert synthetic hydrogels, such as poly(ethylene glycol) (PEG), have 
tunable physical properties independent of their biological activity(5-10). These properties are 
important for regulating cellular differentiation and function(11-13) and can be manipulated 
through PEG hydrogel composition, solid concentration, and crosslinking chemistry.  
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PEG hydrogels are prepared using Michael-type addition (MTA) chemistry, where cysteine-
containing peptides react with the unsaturated groups of the multi-arm PEG(14, 15).  The 
biocompatible chemistry of the MTA reaction allows bioactive modification of the inert PEG 
hydrogels through the incorporation of integrin binding sequences, like RGD, followed by 
crosslinking with protease sensitive peptides. Modification of PEG with monofunctional RGD 
peptides promotes cell adhesion, and crosslinking with di- or trifunctional protease sensitive 
peptides allow migration and proliferation of the encapsulated cells(5, 8, 16, 17). Specifically for 
tissue engineering applications, cysteine containing peptides react with the unsaturated groups of 
the end-functionalized multi-arm PEG to form PEG hydrogels(14, 15). As a result, the 
modification with RGD, or any other monofunctional peptide, leaves fewer “free” reactive arms 
 
Figure 4.1. Crosslinking mechanism for RGD modified multi-arm PEG and YKNR crosslinking 
peptides. This schematic shows the crosslinking kinetics between (A) 4-arm PEG and (B) 8-arm PEG 
that are modified with integrin binding peptides, RGD, and trifunctional protease sensitive 
crosslinking peptide, YKNR, through Michael-type addition. Intermolecular reactions and the 
presence of a third binding site allowed continuation of the network formation. However, bioactive 
modification with integrin binding peptides, RGD, affected crosslinking kinetics by binding to the 
reactive sites on the PEG molecules, preventing network growth at those binding sites. L-Cysteine 
hydrochloride monohydrate (L-Cys) was substituted on a molar basis as a biologically inactive 
surrogate molecule for RGD. 
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available for crosslinking (Fig.4.1). We have demonstrated previously that adding a third 
reactive site to bifunctional crosslinking peptides permits continuation of the hydrogel network, 
improving crosslinking density(18)
 
(Fig.4.1). Despite the improved crosslinking density of 
hydrogels prepared with 4-arm PEG and tri-functional crosslinkers, there are still limitations on 
the extent of modification with RGD. Furthermore, a higher concentration of monofunctional 
peptides results in a greater degree of swelling, which contributes to dilution of the incorporated 
bioactive molecule concentrations in the hydrogel(19). 
The crosslinking kinetics and macroscopic properties of MTA PEG hydrogels depend on pH, 
PEG solid concentration, and the presence of charged amino acid residues(15, 20). However, it 
has not been fully explored how the PEG functionality and the consequences of bioactive 
modification with monofunctional peptides affect the crosslinking kinetics, mechanical 
properties, and the behavior of encapsulated cells. In this study, we investigated the effects of 
increasing the number of reactive groups around the core of the PEG macromer from 4 to 8 on 
the macroscopic properties of the hydrogel, such as swelling and storage modulus. The total 
molar concentration of the reactive functional groups in the conditions comparing 4 and 8-arm 
PEG was identical (e.g. 10mM [–VS] for 5% 4 and 8-arm PEGs), yet we demonstrated that a 
greater local concentration of reactive arms around the core of the PEG macromer resulted in 
improved crosslinking efficiency and reduced network defects stemming from incomplete 
gelation. These findings support our hypothesis that PEG macromers with increased functionality 
allow a greater degree of bioactive modification without compromising the mechanical 
properties of the hydrogel and result in an improved hydrogel design for various biomedical 
applications. 
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4.2  RESULTS 
4.2.1  Storage Modulus of 5% PEG Hydrogels 
First, we studied how the addition of 1.25, 2.5, and 3mM L-Cys affected the storage modulus 
(G’) compared to unmodified hydrogels (0mM L-Cys). Addition of up to 3mM L-Cys to 5% 4-
arm PEG hydrogels allowed complete gelation, which was determined to be the maximal 
concentration of the monofunctional peptide. The storage modulus of unmodified 4 and 8-arm 
PEG hydrogels showed no significant difference after 15min of gelation (Fig.4.2A) or after 
60min (Fig.4.2B). However, upon the addition of L-Cys, storage moduli at 15min and at 60min 
of 4-arm PEG hydrogels were significantly lower compared to those of 8-arm PEG gels modified 
with L-Cys (Fig.4.2A,B). The final G’ of 4-arm PEG hydrogels modified with 3mM L-Cys 
modification only attained 0.8kPa compared to the 1.8kPa of 8-arm PEG gels, and 4.7kPa for 
unmodified 4-arm PEG hydrogels (Fig.4.2B). Modification with L-Cys had a pronounced 
negative effect on gelation and storage modulus of 4-arm PEG hydrogels, especially when the 
reaction was quenched after 15min. In that case, the storage modulus of 4-arm PEG hydrogels 
modified with 1.25mM L-Cys reached only 1.6kPa compared to the 2.9kPa of 8-arm PEG 
hydrogels, and 3.8kPa for unmodified 4-arm PEG hydrogels (Fig.4.2A). This negative effect was 
also observed for the G’ of 8-arm PEG hydrogels with the addition of L-Cys; yet, less 
pronounced compared to 4-arm PEG hydrogels. 
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4.2.2  Rate Formation of PEG Hydrogels 
We performed a time sweep test to determine the rate constant of gelation rate and 
investigate how the addition of bioactive moieties affects the crosslinking kinetics. Overall, the 
rate constant of gel formation was dependent on the number of arms available for crosslinking. 
The rate constant of gel formation of the 8-arm PEG hydrogel was significantly higher than those 
of 4-arm PEG hydrogel at all L-Cys concentrations (Fig.4.2C). The incorporation of L-Cys in 
both 4 and 8-arm PEG hydrogels resulted in a decrease in the rate constant of gel formation and 
 
Figure 4.2. The effect of the L-Cysteine concentration on storage modulus and rate constant of 
gel formation. Time sweep tests were performed at 1 rad/sec and 10% strain to measure storage 
modulus (G’) of 5% 4 and 8-arm PEGs modified with 0, 1.25, 2.5 and 3mM L-Cysteine (A) after 
15min and (B) after 60min of gelation. There were no significant differences between G’ of 
unmodified 4 and 8-arm PEGs (0mM L-Cys). However, G’ of 4 and 8-arm PEG (A) at 15min and (B) 
at 60min was significantly different at all other L-Cys concentrations. (C) Rate constant of gel 
formation of 5% 4 and 8-arm PEGs were significantly different at all conditions. All data is reported 
as mean ± S.D. (n = 3). Significance was determined by a two-way ANOVA followed by Bonferroni 
post-tests with p < 0.05. Double asterisks (**) denoted significance between PEG-4VS and PEG-8VS 
at all L-Cys concentration. Different lower (4-arm) and uppercase (8-arm) letter represent statistically 
significant difference within modified PEG-4VS and PEG-8VS conditions. 
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the decrease was more significant when L-Cys concentration increased. For example, the 
incorporation of 3mM L-Cys caused the rate constant of gel formation to decrease one order of 
magnitude (from 2.0 x 10
-3
 sec
-1 
to 6.5 x 10
-4
 sec
-1
) for 4-arm PEG hydrogels. The decrease in the 
rate constant of gel formation of 8-arm PEG hydrogels also occurred; however, it was less 
significant compared to 4-arm PEG hydrogels. 
 
4.2.3  Swelling of PEG-VS Hydrogels 
4 and 8-arm PEG hydrogels modified with increasing concentrations of L-Cys demonstrated 
significantly increased swelling ratios and a reduced concentration of elastically active chains 
(Fig.4.4B); however, the swelling ratio of 8-arm PEG hydrogels was less affected by the 
incorporation of L-Cys than relative to 4-arm PEG hydrogels (Fig.4.3B). In 5% PEG hydrogels 
with 1.25mM L-Cys modification, 4-arm PEG hydrogels had a swelling ratio 1.4 times greater 
than 8-arm PEG hydrogels. When no L-Cys was added or at a L-Cys concentration of 1.25mM, 
there was no significant difference in the swelling ratio in 5% 8-arm PEG hydrogels in contrast 
to 5% 4-arm PEG hydrogels. Furthermore, 8-arm PEG hydrogels supported efficient network 
crosslinking up to 3.75mM L-Cys modification (Fig.4.3B) when 4-arm PEG hydrogels could 
form with up to 3mM L-Cys content (Fig.4.3A). 
We also compared the equilibrium mass swelling ratio of 4 and 8-arm PEG-VS hydrogels 
with varying solid concentrations from 4 to 10% w/v when the crosslinking reaction was 
quenched after 15min. Gels with PEG concentrations of less than 4% did not form after 15min, 
and gels with PEG concentration above 10% were not investigated due to the small mesh size 
and high storage modulus, which are less suitable for applications involving cells(6). We found 
that a higher concentration of PEG resulted in less swelling for both 4 and 8-arm PEG hydrogels 
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(Fig.4.3C). For example, the lowest Qm values, which are indicative of higher crosslinking 
density, were obtained for unmodified 4 and 8-arm at the 10% PEG concentrations. Even though 
both 4 and 8-arm PEG conditions had the same molar concentrations of reactive groups, 
significantly lower Qm values were observed in 8-arm PEG hydrogels compared to 4-arm PEG 
hydrogels at all PEG concentrations. Similar trends were observed for concentration of 
elastically active chains calculated by using the Flory-Rehner equation (Fig.4.4). 
 
 
Figure 4.3. The effects of L-Cysteine and PEG-VS concentration on swelling ratio. Swelling 
ratios were compared between (A) 5% and 10% 4-arm PEG and (B) 8-arm PEG modified with 0, 1.25, 
2.5 and 3.75mM L-Cys. (A) Swelling ratios of 5% 4-arm PEG hydrogels were significantly different 
from those of 10% 4-arm PEGs at all L-Cys concentrations. Swelling ratios of 5% 4-arm PEGs with 
0mM L-Cys were significantly different from those of 5% 4-arm PEGs modified with 1.25 and 
2.5mM L-Cys. However, swelling ratios of 10% 4-arm PEGs with 3.75mM L-Cys was only 
significantly different from those of all 10% 4-arm PEGs. (P<0.001) An 'X' denotes conditions that did 
not form gels. (B) For 8-arm PEG hydrogels, swelling ratios of 5% 8-arm PEGs were significantly 
different from those of 10% 8-arm PEGs at all L-Cys concentrations. However, there was no 
significant difference among any 10% 8-arm PEGs at all L-Cys concentrations (P<0.01) (C) Swelling 
ratios of 4-arm PEGs were significantly different from those of 8-arm PEGs at all PEG concentrations. 
All data is reported as mean ± standard deviation (n = 8). Significance was determined by a two-way 
ANOVA followed by Bonferroni post-tests. Double asterisks (**) denoted significance between PEG-
4VS and PEG-8VS at all L-Cys concentration (p < 0.01). Different lower (4-arm) and uppercase (8-
arm) letter represented statistically significant difference within modified PEG-4VS and PEG-8VS 
conditions (p < 0.05). 
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4.2.4  Material Properties Comparisons Between 5% PEG-VS and PEG-A Hydrogel 
Different reactive end groups, such as acrylate (PEG-A) and vinylsulfone (PEG-VS), have 
the ability affect the mechanical properties of PEG MTA hydrogels. We investigated whether 
PEG functionality and the degree of modification demonstrate similar trends across various end 
groups of PEG in crosslinking efficiency and macroscopic properties. The PEG-VS and PEG-A 
macromers are identical in structure besides their reactive end groups. The considerable 
differences in resulting material properties among different MTA reactive groups arise from 
differences in electronegativity of the end groups affecting the crosslinking efficiency(21). The 
main difference between the two functional end groups was the range of possible L-Cys 
modification in 5% 4-arm PEG hydrogels. PEG-4A hydrogels could form with a maximum of 
1.25mM when PEG-4VS supported efficient network crosslinking up to 3mM L-Cys 
modification (Fig.4.5A). Overall, both PEG-8VS and PEG-8A demonstrated more efficient 
crosslinking compared to either 4-arm PEGs. As an example, the rate constant of gel formation 
of both PEG-8VS and PEG-8A was significantly higher than those of both PEG-4VS and PEG-
4A at all L-Cys concentrations (Fig.4.5B). Also G’ of both 4-arm PEG hydrogels modified with 
 
Figure 4.4. Concentration of elastically active chains. (A) Concentrations of elastically active 
chains of 8-arm PEG were greater than those of 4-arm PEG at all biologically relevant PEG solids 
concentration, indicating a higher PEG functionality would favor intermolecular reactions between 
elastically active binding sites. (B) Concentrations of elastically active chains of 8-arm PEG were 
available up to 3.75mM L-Cysteine modification when they were only available up to 3mM L-
Cysteine modification in 4-arm PEG hydrogels, confirming experimental data on how PEG with 
higher number of functional binding sites allowed greater degree of biological modification. 
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1.25mM L-Cys at 15min was significantly lower than G’ of both 8-arm PEG hydrogels modified 
with 1.25mM L-Cys at 15min (Fig.4.5C). However, there was no significant difference between 
any measurements of swelling ratio (Fig.4.5A). Overall, the trend of an increase in swelling ratio 
and a decrease in storage modulus with the addition of L-Cys was similar in PEG-A. 
Modification with L-Cys had a less pronounced negative effect on gelation and storage modulus 
 
Figure 4.5. Comparison of PEG-VS and PEG-A. (A) Swelling ratio, (B) the rate constant of gel 
formation, storage modulus (C) after 15min of gelation and (D) after 60min were compared between 
5% 4-arm PEG and 8-arm PEG hydrogels (PEG-VS and PEG-A) modified with 0, 1.25, and 3mM L-
Cys. For swelling ratio, there was no statistical difference between PEG-VS and PEG-A at all 
conditions. However, PEG-4A gels could form with a maximum of 1.25mM when PEG-4VS 
supported efficient network crosslinking up to 3mM modification. The rate constant of gel formation 
of both PEG-8VS and PEG-8A was significantly higher than those of PEG-4VS and PEG-4A at all L-
Cys concentration. G’ of both unmodified 8-arm PEGs after (C) 15min and (D) 60min was 
significantly higher from G’ of both unmodified 4-arm PEGs; however, upon addition of L-Cys, there 
were no significant differences between G’ of PEG-8A and both 4-arm PEGs. An 'X' denotes 
conditions that did not form gels. All data is reported as mean ± S.D. (A) n = 8, (B – D) n = 3. 
Significance was determined by a two-way ANOVA followed by Bonferroni post-tests. A single 
asterisk (*) denoted significance among groups of PEG-VS and PEG-A (both 4 and 8-arm) modified 
with a same L-Cys concentration. Different lower (4-arms) and uppercase (8-arms) letter represented 
statistically significant difference within modified PEG-VS and PEG-A groups (both 4 and 8-arm) (p 
< 0.05).  
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of both PEG-8VS and PEG-8A compared to PEG-4VS and PEG-4A, especially when the 
reaction was quenched after 15min (Fig.4.5C). 
4.2.5  PEG Functionality and the Bioactive Modification Affect Cellular Growth and 
Behavior 
PEG hydrogels with the same solid concentrations, but modified with different RGD 
concentrations, exhibit different mechanical properties. Here, we encapsulated and cultured HS-5 
cells in 5% 4 and 8-arm PEG hydrogels modified with 0.25mM and 1.25mM RGD (Fig.4.6). To 
isolate the effect of the concentration of biological cues, we incorporated 1mM L-Cys to PEG 
hydrogels modified with 0.25mM RGD to mimic the same mechanical properties of PEG gels 
modified with 1.25mM RGD by blocking the same number of reactive arms. These hydrogels 
were crosslinked with the plasmin sensitive tri-functional crosslinking peptide composed of 
fibrin-derived sequences, YKNR, to allow proteolytic degradation(18). 
HS-5 cells cultured in 5% 8-arm PEG hydrogels modified with 1.25mM RGD exhibited 
fibroblast-like spindle morphology starting at Day 4 and stromal networks began to form through 
affixing with other adjacent cell populations by Day 12 (Fig.4.6B). In 5% 4-arm PEG hydrogels 
modified with 1.25mM RGD, HS-5 cells started to express fibroblast-like spindle morphology at 
Day 8; however, stromal networks were not as dense nor interconnected as those observed in 5% 
8-arm PEG modified with 1.25mM RGD (Fig.4.6A). Despite a less dense network, spheroid 
formation was still observed in 5% 4 and 8-arm PEG gels modified with 0.25mM RGD, which 
was confirmed by multiple nuclei DAPI staining (Fig.4.6A,B). In addition, although a reduction 
in the concentration of RGD limited cell network growth, cells were viable in gels modified with 
0.25mM RGD (Fig.4.7). 
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Figure 4.6. The effect of the RGD concentration on human bone marrow stromal cells growth 
and the network formation. Stromal cells derived from human bone marrow (HS-5) [2 x 10
6
 
cells/mL] were encapsulated in 5% (A) 4-arm and (B) 8-arm PEG-VS modified with 0.25mM RGD 
and 1.25mM RGD and cultured up to Day 12. HS-5 cultured in 5% 8-arm PEG-VS modified with 
1.25mM RGD formed more interconnected and complete network. In contrast, HS-5 cultured in 4-arm 
PEG-VS and 8-arm PEG-VS modified with 0.25mM RGD + 1mM L-Cysteine formed spheroids 
confirmed by multiple nuclei observed using DAPI staining due to insufficient cell adhesion. Scale 
bar: White = 200μm, Black/DAPI = 100μm (C) GFP transfected Human bone marrow stromal cells 
(GFP HS-5) [2 x 10
6
 cells/mL gels] were encapsulated in 5% 8-arm PEG-VS modified with 0.25mM 
RGD + 1mM L-Cysteine and 1.25mM RGD and cultured up to Day 12. GFP HS-5 cultured in 5% 8-
arm PEG-VS modified with 1.25mM RGD formed more interconnected and complete network. 
Images were taken using a confocal microscope Nikon A1. Scale bar: 100μm. 
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4.3  DISCUSSION 
In this study, we aimed to investigate how the modification of PEG macromers with 
monofunctional groups affects the material properties. Considering that there are equal molar 
concentrations of reactive end groups participating in the reaction, we hypothesized that a greater 
number of arms per molecule core would allow a greater degree of bioactive modification 
without affecting the mechanical properties of the hydrogel. Interestingly, the crosslinking 
kinetics and the storage modulus of unmodified 4 and 8-arm PEG gels were not affected by the 
spatial distribution of arms around the core of the PEG macromer. In contrast, incorporation of 
biological cues dramatically affected the storage modulus and the crosslinking kinetics of 
modified 4-arm PEG gels compared to the 8-arm PEG gels.  
The rate constant of gel formation of 4 and 8-arm PEG gels was significantly different at all 
L-Cys concentrations and the most significant differences were observed during the first 15min 
of crosslinking. These results indicate that increasing the spatial distribution of arms around the 
 
Figure 4.7. LIVE/DEAD assay on 5% 4-arm PEG-VS on Day 12. Human bone marrow stromal 
cells (HS-5) viability was confirmed by LIVE/DEAD assay. High Calcien AM (Green) staining 
confirmed the cell viability was not significantly affected by the RGD concentration. Scale bar: 
200μm. 
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core of the PEG macromer attenuates the negative effect of modification on the crosslinking 
kinetics and storage modulus.  
We also investigated whether PEG functionality and the degree of modification demonstrate 
similar trends across various end groups of PEG in crosslinking efficiency and macroscopic 
properties. The PEG-VS and PEG-A macromers are identical in structure besides their reactive 
end groups; however, the considerable differences in resulting material properties were observed. 
The significant differences in the gel formation kinetics and the storage modulus of PEG-VS and 
PEG-A resulted from the differences in reactivity of the end groups. A sulfone group of PEG-VS 
has a higher electron withdrawing capability than a carbonyl group of PEG-A, making the vinyl 
moiety more electron deficient, and more reactive with the electron rich thiol group compared to 
the acrylate(22). Due to more reactive vinyl sulfone moiety, unmodified PEG-VS demonstrates 
higher storage modulus after 15 and 60min compared to PEG-A regardless of the number of 
reactive end groups. Also, the bioactive modification had a less pronounced negative effects on 
the properties of PEG-VS compared to PEG-A due to the same reason. Importantly, increasing 
bioactive modification resulted in similar trends of decreased storage modulus, reduced rate of 
gel formation, and increased swelling in both PEG-A and PEG-VS hydrogels. 
According to the MTA chemistry of the hydrogel formation, the number of reactive arms, 
elastically inactive loop formation, and entropy are related to this phenomenon. First, the 
formation of elastically inactive loops is more critical in PEG with lower functionality because 
the effective crosslink functionality must be greater than two in order for networks between any 
elastically active chains to occur(20). Second, based on previous studies involving Monte Carlo 
simulation of many-chain star polymers(23, 24), an increase in the number of arms causes an 
expansion of the arms due to the influence of three-body effects in the central regions of the 
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“core”. As a result, when the number of arms is high, the segment density near the core is much 
higher than in the periphery, as described by the model of Daoud and Cotton(25). Therefore, this 
core effect reduces the interpenetration and overlap of other macromer’s arms; thus, there is a 
higher probability for a greater number of the end functional groups to be exposed at a given 
time for efficient crosslinking to occur(26). Finally, the mobile tip of the chain encounters an 
entropic potential barrier that penalizes deep fluctuations needed to bring the tip to the tethering 
point(27). As the number of arms on the macromer increases, there is progressively less space 
left for the local fluctuation of the chains(25), meaning that 8-arm PEG would encounter a lower 
entropic potential barrier compared to 4-arm PEG. 
Bioactive modification of PEG hydrogels is done by incorporating integrin binding 
sequences like RGD; however, monofunctional RGD occupies the same reactive sites on the 
PEG molecules used for the crosslinking reaction, thus affecting its material properties. In this 
study, we measured the equilibrium swelling ratio (Qm) of 4 and 8-arm PEG hydrogels because 
Qm correlates with crosslinking density and serves as an indication of overall hydrogel network 
structural defects, such as multiple primary loops and dangling ends(15, 20). Qm is also relevant 
in biological applications since high swelling is known to mitigate the effects of incorporated 
RGD due to dilution(28). Overall, a greater PEG solid concentration resulted in less swelling and 
better network formation regardless of the number of arms. Even with the presence of added 
biological cues, 8-arm PEG hydrogels had significantly lower Qm values and demonstrated a 
greater range of modification compared to 4-arm PEG at all concentrations. Lower Qm values of 
modified 8-arm PEG hydrogels compared to those of 4-arm PEG hydrogels indicated a more 
densely crosslinked networks, which also correlated with a higher storage modulus. Similarly, 
the calculations using the Flory-Rehner equation of the concentration of elastically active chains 
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predicted more elastically active chains in 8-arm PEG at all biologically relevant PEG solid 
concentrations (4 – 10% w/v) compared to 4-arm PEG (Fig.B1A). Both experimental data and 
theoretical calculations confirmed how functionality is directly related to effective crosslinking 
and the concentration of elastically active chains. This implies that additional types and 
concentrations of biological cues, such as growth factors, can be incorporated into 8-arm PEG 
hydrogels for further modification(7, 8, 29). 
To investigate how the changes in macroscopic properties induced by bioactive modification 
affect cellular behavior and function, we encapsulated and cultured HS-5 cells in 4 and 8-arm 
PEG hydrogels. Cell growth and stromal network formation were observed in 8-arm PEG 
hydrogels modified with 1.25mM RGD. We also found that HS-5 cells cultured in both 4-arm 
and 8-arm PEG hydrogels modified with 0.25mM RGD formed spherical multicellular 
aggregates (spheroids). Spheroid formations were previously described in anchorage-dependent 
cell lines on non-adherent surfaces or in bio-inert polymers(30, 31). Multiple reports have shown 
that spheroid formation is directly related to cell-cell contacts that regulate cell survival and 
growth, which was shown to be dependent on integrin-mediated cell contacts and RGD 
peptides(32, 33). As a result, we concluded that 0.25mM was an insufficient RGD concentration 
to promote appropriate cell adhesion and growth. More importantly, HS-5 cells cultured in 4-arm 
PEG hydrogels modified with 1.25mM RGD did not form as dense and interconnected stromal 
networks as they did in the 8-arm PEG modified with 1.25mM RGD. The 4-arm PEG gel, in this 
case, had a swelling ratio 1.4 times greater than the 8-arm PEG, demonstrating the negative 
effect of swelling on cell growth and matrix remodeling. The more swollen matrix of the 4-arm 
PEG hydrogel was inferior because swelling is known to mitigate the effects of incorporated 
RGD due to dilution(28) (e.g. 1.25mM RGD gets diluted to 0.34mM after swelling for 4-arm 
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PEG gels). These results demonstrate that bioactive modification not only affects the PEG 
hydrogel’s macroscopic properties, but also regulates cellular behavior and function. 
 
4.4 CONCLUSIONS 
Bioactive modification affected the mechanical properties of multi-arm PEG gels, such as 
storage modulus and swelling, as a consequence of the macroscopic network changes. These 
changes were dependent on PEG functionality (4 vs. 8-arm) and PEG solid concentrations, 
which are directly related to the concentration of elastically active chains and the overall amount 
of binding sites. Overall, 8-arm PEG allowed a greater degree of modification and its 
macroscopic properties and crosslinking kinetics were less affected by the act of modification or 
quenching compared to 4-arm PEG. These advantages provide a finely tuned design for various 
biological applications with broad range of bioactive modification. 
 
 
4.5 Materials & Methods 
4.5.1 Hydrogel Materials  
Hydrogels for mechanical and physical characterization studies were prepared with 4 and 8-
arm PEG vinyl sulfone (PEG-VS, 20kDa and 40kDa, >99% purity, Jenkem Technology). The 
hydrogels were formed via MTA with plasmin sensitive tri-functional crosslinking peptides A- 
GCYK↓NRGCYK↓NRCG (YKNR) (1663.91 g mol-1, >90% purity, GenScript, cleavage site 
indicated by ↓) for all experiments. The stoichiometric ratio of -VS to thiol (-SH) groups was 
kept constant at 1:1 ratio for all experiments. PEG hydrogels were modified with the integrin 
binding peptide GCGYGRGDSPG (RGD) (1067.10 g mol
-1
, GenScript) to allow attachment of 
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the encapsulated cells. For experiments without cells, L-Cysteine hydrochloride monohydrate (L-
Cys) (98.5-101.0%, F.W. 175.64 g mol
-1
, Fisher BioReagents) was substituted on a molar basis 
as a biologically inactive model compound for RGD(7). All methods and conditions for 4 and 8-
arm PEG acrylate (PEG-A, 20kDa and 40kDa, >99% purity, Jenkem Technology) hydrogels 
were identical. 
4.5.2 Rheology – Storage Modulus and the Rate Constant of Gel Formation  
The storage modulus (G’) and the rate constant of gel formation were studied using AR-G2 
rheometer (TA Instruments, New Castle, DE) equipped with 20mm parallel plates and a Peltier 
stage was utilized for mechanical testing. We compared 4 and 8-arm PEG-VS hydrogels (5% 
w/v) crosslinked with YKNR peptide and modified with varying concentration of L-Cys, ranging 
from 0 to 3mM. After 100µl of the PEG solution was mixed with YKNR peptide, the mixture 
was directly pipetted between the rheometer's plates and each test was conducted at 37
o
C for a 
60min time sweep at 10% strain and 1 rad/sec. The rate constant of gel formation was calculated 
from G’ curves by using the curve fit tool in MATLAB (Natick, MA). A non-linear regression 
was performed using the equation: 
𝑌 = 𝑌0 + (𝑃𝑙𝑎𝑡𝑒𝑎𝑢 − 𝑌0) × (1 − exp(−𝐾 × 𝑡)) 
The storage modulus at the initial time, t=0, is defined as Y0. In the above equation, the term 
Plateau is the storage modulus, G’, after complete gelation, K represents the rate constant for gel 
formation in unit of reciprocal time, and t represents time. 
4.5.3 Swelling of the PEG hydrogels  
Hydrogels (4 and 8-arm PEG) at various final concentrations (4 – 10% w/v) were crosslinked 
with YKNR and modified with L-Cys at concentrations ranging from 0 to 3.75mM. Hydrogels 
were prepared by dissolving each precursor in 0.05M HEPES buffer at pH 7.4. For example, to 
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make 100µl of PEG-8A 5% gel with 1.25mM L-Cys, 5mg of PEG-8VS/PEG-8A was dissolved 
in 45µl of HEPES buffer and mixed with 0.022mg of L-Cys in 10µl of HEPES buffer. Larger 
volumes of stock solutions were prepared to minimize weighing error. L-Cys was allowed to 
bind to the PEG macromer’s reactive sites at 37oC for 15min. Next, 0.49mg of YKNR was 
dissolved in 40µl HEPES buffer at a 1:1 molar ratio of the functional groups in PEG. 
Afterwards, the YKNR solution was pipetted into the modified PEG solution and mixed, 
vortexed, and pipetted into 20μl gels. After 1min, the reaction was quenched and PEG gels were 
submerged in 15ml of MilliQ water for 24h. After 24h, excess water was removed and the gels 
were weighed. The mass swelling ratio (Qm) was calculated by dividing the mass of the swollen 
hydrogels (ms) by the mass of the dry gel components (md)(34, 35). 
𝑄𝑚 =
𝑚𝑠
𝑚𝑑
 
4.5.4 Elastically Active Chain Concentration  
Elastically active chain concentration in the PEG network was calculated by using the 
modified Flory-Rehner equation that shows a direct relation between the PEG precursor weight 
percent and associated Qm(15). 
𝑣𝑒 = −
𝑉𝑑
𝑣1
[ln(1 − 𝑣2,𝑠) + 𝑣2,𝑠 + 𝑋1𝑣2,𝑠
2 ]
𝑣2,𝑐 [(
𝑣2,𝑠
𝑣2,𝑐
)
1
3
−
1
2 (
𝑣2,𝑠
𝑣2,𝑐
)]
 
In the Flory-Rehner equation, X1, polymer-solvent interaction parameter, is equal to 0.43 for 
PEG in water, Vd is the polymer volume in the dry state, and v1 is the molar volume of water in 
cm
3
/mol. v2,s is the equilibrium polymer volume fraction after swelling has occurred (1/Qm)(36), 
and v2,c is the polymer volume fraction at crosslinking. 
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4.5.5 HS-5 Green Fluorescent Protein (GFP) Transfection and Culture 
Human bone marrow stromal cell line, HS-5 cells (ATCC) were cultured in DMEM 
(Dulbecco’s modified Eagle’s medium, ATCC) supplemented with 10% fetal bovine serum 
(FBS) (Biowest) and 1% PenStrep (Lonza). The cells were cultured in T-75 flasks in 5% CO2 
atmosphere at 37
o
C and split in a 1:5 ratio every 3-4 days. For confocal fluorescent imaging HS-
5 cells were transfected with Green Fluorescent Protein (GFP)(37). Briefly, 24 hours prior to 
transfection, HS-5 cells were seeded and cultured in 6 well plates. Once cell confluency reached 
60% a transfection reagent Fugene 6 (Promega), was first mixed with serum-free Opti-Mem 
media (Invitrogen) and sequentially with DNA (pLenti-GIII-GFP) (Applied Biological 
Materials) according to the manufacturer’s instructions.  This mixture was carefully added 
dropwise and then incubated at 37°C for 24 – 48 hours. After verifying HS-5 was successfully 
transfected with GFP, transfected cells were selected and cultured in media supplemented with 
puromyocin (1μg/ml) (Sigma-Aldrich). 
4.5.6 HS-5 Cell Encapsulation and 3D Culture in PEG Hydrogels 
Prior to in situ crosslinking and encapsulation, HS-5 cells were suspended at a concentration 
of 2 x 10
6
cells/mL and centrifuged for 5min at 300G to remove excess media. In order to 
investigate the effects of RGD concentration on 3D cell behavior without inducing changes in 
hydrogel mechanical properties, the total concentration of monofunctional cysteine groups 
composed of L-Cys and RGD peptide was kept constant at 1.25mM. We prepared 5% PEG-4VS 
or PEG-8VS by dissolving PEG in the appropriate amount of 0.05M HEPES Buffer at pH 7.4, 
followed by modification with 1.25mM RGD or 0.25mM RGD plus 1mM L-Cys. The 
monofunctional agents were allowed to bind to the PEG macromers at 37
o
C for 15min. Then, the 
cell pellet was reconstituted with modified 4-arm or 8-arm PEG and formed gels by the addition 
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of trifunctional plasmin sensitive crosslinking peptide, YKNR. The stoichiometric ratio VS:SH 
was kept 1:1 for all experiments. Each 50μl gel was crosslinked between two glass slides at 37oC 
for 15min and flipped at 7min to prevent cell sedimentation and clustering. After 15min, gels 
were placed in a 48 well plate and covered with 400µl of DMEM. Media was changed every 2 
days and cells were cultured up to 12 days. All images were taken using Leica DMI3000B and a 
confocal microscope Nikon A1 was used for imaging GFP transfected HS-5 cells. 
4.5.7 DAPI Staining and Cell Viability Assay 
Cells were stained with DAPI (Invitrogen) and LIVE/DEAD kit (488/570) (Invitrogen) at 
Day 12 to evaluate cell viability as described by the manufacturer’s protocol. DAPI stain was 
added directly to cells in full media and incubated for 15 min. Spheroid formation was identified 
by multiple nuclei staining. All images were taken using Leica DMI3000B. 
4.5.8 Statistical Analysis 
All statistical analyses were performed using GraphPad Prism (GraphPad Prism Software, La 
Jolla, CA). Data are reported as mean ± standard deviation of measurements, and statistical 
analyses were performed with Two-way ANOVA followed by Bonferroni post-test. 
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CHAPTER V 
 
 
Synthetic hydrogel supports the function and regeneration 
of artificial ovarian tissue in mice 
 
 
5.1 Introduction 
The number of cancer survivors has been growing due to advancements in anticancer 
treatments, and the long-term survival rates improved above 80% in most childhood 
malignancies(1, 2). Yet, cytotoxic chemotherapy, radiotherapy and bone marrow transplantation 
treatments often cause infertility and premature ovarian failure(3, 4). Clinically approved fertility 
preservation options exist only for adult patients who can produce a fully mature egg(5). If the 
anticancer treatment can be delayed, these patients can undergo hormonal stimulation to 
stimulate follicle development and recover mature oocytes(6). The retrieved oocytes can then be 
cryopreserved and used later for in vitro fertilization (IVF) treatments. Unfortunately, the option 
of egg preservation is not applicable to patients who require immediate treatment or 
prepubescent girls, whose dormant ovaries cannot produce mature eggs(6). Furthermore, the 
cytotoxic chemotherapy affects the ability of the prepubescent girls to undergo complete and 
physiological puberty(7). This eventually leads to a variety of long-term clinical complications, 
such as delayed growth of bones, impaired cognitive development, cardiovascular and metabolic 
complications(8). 
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Autotransplantation of cryopreserved ovarian tissue has shown promising results for fertility 
and ovarian function restoration and has resulted in 60 reported live human births since 2004(9). 
Unlike in vitro maturation and fertilization of mature eggs, transplantation of ovarian tissue does 
not require repeated cycles of hormone stimulation, thus reducing risk of ovarian 
hyperstimulation syndrome and delay in chemotherapy treatments(10). Despite promising 
results, there is a significant loss of the follicular pool due to tissue ischemia and it requires 
multiple invasive procedures to extend ovarian function because of the short life span of 
autografts(11-13). Yet, the most prohibitive limitation of the ovarian tissue autotransplantation is 
a potential risk for re-introducing malignant cells, especially in patients with leukemia and other 
blood-borne cancers(14). Therefore, grafting of multiple isolated follicles presents a safer 
alternative because individual follicles are separated from the stromal environment before being 
encapsulated in a three-dimensional supportive matrix. 
Ovarian tissue contains follicles at different developmental stages surrounded by stroma cells 
and rich vasculature. Follicles, the functional units of the ovary, are composed of a germ cell (the 
oocyte) and layers of somatic cells (granulosa and theca cells), which are responsible for the 
production and metabolism of gonadal hormones, estradiol and progesterone. At birth, the 
human ovary contains approximately one million of immature follicles, called primordial 
follicles, which have the potential to develop and produce mature oocytes capable of 
fertilization. This number decreases to 300,000 follicles at puberty and continues to decline until 
menopause(15). Because of the non-regenerative nature of follicles, a sufficient number of 
follicles must be present in the ovary in order to sustain ovarian endocrine function.  
Primordial follicles, the most immature and most abundant class of follicles, constitute the 
ovarian reserve, and activation of a small portion of this reserve each cycle ensures ovarian 
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function(15). Activated primordial follicles enter the growing pool of preantral follicles and 
secrete sex hormones. A burst activation of premature follicles can shorten the longevity of the 
graft. A successful transplantation would require significant primordial follicle population, which 
can contribute to monthly cycles and provide healthy, fertilizable eggs(6, 16-18). Several reports 
have investigated an approach of grafting enzymatically-isolated immature follicles encapsulated 
in naturally derived hydrogels, such as alginate(19), fibrin(20-22), fibrin and vascular endothelial 
growth factor (VEGF)(21, 23), for delivery of isolated follicles and demonstrated complete 
folliculogenesis in vivo showing the potential of this approach. Here, for the first time, we report 
the application of synthetic hydrogels with defined degradation kinetics and tunable physical 
properties(24) to support long-term engraftment and function of the artificial ovarian tissue. 
To address the limitations of fertility preservation options available only to a small subset of 
patients, we investigated whether an engineered ovarian tissue supports the ovarian endocrine 
function in sterile mice. We constructed an artificial ovary from pre-antral follicles encapsulated 
in a tunable synthetic hydrogel, poly(ethylene glycol) vinyl-sulfone (PEG-VS), as a supportive 
matrix. The tunable biophysical and biochemical properties(24, 25) of PEG hydrogels 
successfully mimic the native complexity of the extracellular matrix. End-functionalized multi-
arm PEG-VS allows modification with integrin-binding peptides (such as RGD) to allow cell-
matrix interactions(26, 27) and crosslinking with protease-sensitive peptides to allow cell-driven 
degradation and remodeling of the matrix. PEG-based matrices support folliculogenesis in 
vitro(28), vascularization of tissue constructs in vivo(29) and promote matrix remodeling in bone 
defects(30, 31). We hypothesized that PEG-VS hydrogels modified with RGD and crosslinked 
with MMP-sensitive peptide can serve as a supportive matrix for an engineered artificial ovarian 
tissue. Matrix with MMP sensitive peptide would allow cell and follicle driven remodeling as the 
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abundance of collagen in the natural ovarian tissues undergoes remodeling during follicular 
development and ovulation(32). We evaluated the development of immature follicles 
encapsulated in PEG hydrogels and assessed the graft function after orthotopic transplantation 
into ovariectomized mice. Our results demonstrated for the first time that synthetic PEG 
hydrogels with proteolytically-controlled degradation successfully supported follicle growth and 
promoted graft remodeling in vivo. 
 
5.2. Results 
5.2.1. Development of encapsulated immature follicles 
Histological analysis of PEG hydrogels explanted 14, 30, and 60 days after transplantation 
was performed to evaluate the development of the implanted follicles. The initial population of 
the follicles (day 0) was mostly primordial follicles (67.6%) with 30.8% primary and a small 
percentage (1.6%) of secondary follicles (Fig.5.2E). Antral follicles appeared 14 days after 
transplantation (Tx), which is consistent with the fact that the transition from primordial to antral 
takes 14 to 18 days during normal folliculogenesis in mice(33)(Fig.5.2F). Multiple fully mature 
pre-ovulatory follicles were observed in the grafts retrieved after 30 (Fig.5.2G) and 60 days 
(Fig.5.2H) post-Tx, which indicated the progression and the extent of the follicle development 
during this period. From day 14 to day 60, the proportion of secondary and antral follicles 
increased by 7.7 times and 36 times, respectively (Fig.5.3B), and tissue regeneration progressed 
as encapsulated follicles were going through follicle development (Fig.5.2B – D). 
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5.2.2. Immature follicular pool sustained 
We quantified the number and the distribution of follicles per gel before and after 
transplantation to evaluate the follicular reserve (Fig.5.3A, 5.3B). There was a decreasing trend 
of the primordial follicle number and an increasing trend of the antral follicle number over 60 
days in grafts (Fig.5.3A). This was a result of primordial follicles entering the growing pool 
every estrous cycle and reaching fully mature pre-ovulatory follicles. The variability in the initial 
number of follicles encapsulated in the graft was due to the loss of follicles during the 
sedimentation and encapsulation processes. The expected decreasing trend of the early stage 
follicle numbers in grafts (Fig.5.3A) indicates a functioning graft that activates a small cohort of 
 
Figure 5.1 – The timeline for inducing premature ovarian failure and grafting artificial ovarian tissue: 
(A) A bilateral ovariectomy (OvX) was performed to induce premature ovarian failure in mice. In 
order to maintain the space within the bursa after OvX, inert alginate beads (black arrow) were 
inserted to prevent the collapse and adhesion. (B) Follicles were enzymatically isolated from three 6 or 
7 days old female mice. (C) Follicles were encapsulated in 7% PEG-8VS (0.5mM RGD) crosslinked 
with LGPA hydrogels. One PEG grafts with enzymatically isolated follicles was transplanted (Tx) into 
each ovarian bursa, two implants per mouse. PEG grafts were retrieved (D) 14 (nmice=11), (E) 30 
(nmice=6), (F) 60 (nmice=6), and (G) 90 (nmice= 5) days after Tx.  [FP: Fat pad, S: Sutures (Dotted 
arrows), BV: Blood vessels, AF: Antral follicle] 
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follicles each estrous cycle.  Multiple growing follicles at the primary and early secondary stages 
were observed 14 days after transplantation. As primordial follicles were recruited into the 
growing pool, a 51.4% decrease of primordial follicles occurred over 60 days in vivo. However, 
60% of the immature follicular pool, including both primordial and primary follicles, was still 
present in the grafts at day 60 (Fig.5.3B). Based on histological analysis, both primordial and 
primary follicles were observed adjacent to secondary follicles (Fig.3C), showing selective 
activation and recruitment of primordial follicles into the growing pool. 
 
5.2.3. Restoration of Hypothalamus-Pituitary-Gonadal (HPG) axis 
Ovariectomy (OvX), and the subsequent absence of circulating gonadal hormones produced 
in the ovaries, disrupts the negative feedback loop of the hypothalamus-pituitary-gonad (HPG) 
axis. The most immediate and pronounced clinical outcome after removal of the ovaries is 
disruption and absence of regular estrous cycles as well as elevated FSH levels. To investigate  
 
Figure 5.2 – Folliculogenesis in PEG grafts: (A – D) Over 60 days, massive volumetric expansion 
was observed during the complete folliculogenesis, beginning with the (E) mixed population of 
primordial and primary follicles to (F - H) antral follicles, and more tissue regeneration occurred. 
Antrum formation was observed by day 14. By day 30 and 60, multiple antral follicles were observed. 
[Primordial (dotted arrow), Primary follicle (**), Secondary follicle (***), Antral follicle (X)] Scale: 
500µm (A – D), 50µm (E), 100µm (F – H). 
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Figure 5.3 - Follicle development and progression through the developmental stages: (A) The number 
of follicles in each graft at different stages after transplantation. There was a decreasing trend of the 
primordial follicle number in grafts over 60 days as a result of entering the growing pool every estrous 
cycle, ovulate and become corpus lutea. The distribution in the follicle numbers before transplantation 
resulted due to the loss of follicles during encapsulation process. (ngel = 4 from 4 mice, for each time 
point) Statistical significance was determined by the Kruskal-Wallis test followed by Dunn’s post-test 
(p < 0.05). (B) Graft composition and percentage of the follicles at each developmental stage.  After 
14 days in vivo the majority of the implanted follicles were at primordial stage, similar to the graft 
composition at the implantation. After 30 days, 15% of the implanted follicles reached a pre-antral 
stage and 5% were antral. The percentage of primordial follicles decreased and the percentage of 
growing follicles increased over 60 days in vivo. 60% of immature follicular pool, including both 
primordial and primary follicles, was still presented in the grafts. (C) Primordial and primary follicles 
present at day 14, 30 and 60 after implantation. [Primordial follicles (dashed arrow), Primary follicle 
(**), Secondary follicle (***)] Scale: 50µm 
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how the graft contributes to the restoration of HPG axis, follicle-stimulating hormone (FSH) 
levels were measured before and after transplantation (Fig.5.4A). As expected, serum FSH levels 
significantly increased post-OvX (from 8 ng/mL to 64 ng/mL) and the levels remained 
constantly elevated up to 14 days post-Tx. 
 
Figure 5.4 – Graft function: (A) FSH level significantly increased post-OvX, confirming the complete 
OvX. For the group transplanted with PEG graft, FSH level decreased beginning at 35 days post-Tx 
(**), and FSH level declined to Pre-OvX levels by 49 days post-Tx, confirming the restoration of 
HPG axis. High FSH level persisted throughout for the control group that did not receive PEG graft 
with follicles. All data is reported as mean ± S.D. [With PEG graft: D-14 ~ D28 (nmice = 11), D35 ~ 
D60 (nmice = 6)]. An asterisks (*) denoted significance within the group transplanted with PEG graft 
compared to pre-OvX (D-14). Statistical significance was determined by a one-way ANOVA followed 
by Tukey’s test (p < 0.01). (B) Vaginal cytology demonstrated resumed cyclicity in 50% of mice after 
7 days post-Tx and 100% by 14 days. Cyclicity was maintained up to 60 days, supporting 12 – 15 
estrous cycles in mice. (nmice = 4) (C) Corpora lutea (CL) were observed at 30 and 60 days post-Tx, in 
agreement with the FSH levels. CL formation suggests ovulatory events and they showed the typical 
characteristic of centrally located blood clot (dashed outline). 
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The elevated FSH levels, ranged from 64 to 76 ng/mL, persisted without the implantation of 
PEG grafts throughout the study in the control group. However, FSH levels consistently 
decreased in mice that received the PEG grafts, as the transplanted follicles initiated 
folliculogenesis and steroidogenesis. The FSH levels declined to 36ng/mL by day 35 post-Tx, 
and 13ng/mL by day 49. The physiological levels of FSH were maintained up to day 60 
(10ng/mL), confirming the restoration of the HPG axis. The resumption of the estrous cycle 14 
days post-Tx in all the transplanted mice further confirmed the presence of functioning artificial 
 
Figure 5.5 – Graft remodeling and revascularization: Functioning blood vessels (arrows) were found 
after (A) 30 days and (B) 60 days in vivo, as indicated by the presence of red blood cells (box). Scale 
bar: 100µm, box: 50µm (C) CD34 staining (arrows) confirmed the infiltration of blood capillaries into 
the graft. (D) Blood vessel density (number of blood vessel (nb)/mm
2
) significantly increased from 30 
days to 60 days post-Tx, confirming more progressed remodeling process. Neovascularization was 
observed in 3 out of 5 mice for 30 days post-Tx and 4 of 5 mice for 60 days. Statistical significance 
was determined by the Mann-Whitney test (p = 0.1).  
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ovarian tissue (Fig.5.4B). Presence of CL in the histological sections collected after 30 and 60 
days served as an important evidence of successful ovulation, which was consistent with regular 
estrous cyclicity (Fig.5.4C). 
5.2.4. Graft remodeling and neovascularization  
The degree of remodeling and neovascularization of the implanted PEG hydrogel directly 
impacts the graft longevity. Functioning blood vessels were found after 30 (Fig.5A) and 60 
(Fig.5.5B) days post-Tx, which was indicated by the presence of red blood cells in the lumen of 
the vessels. The presence of the blood capillaries was confirmed by positive CD34 
immunostaining (Fig.5.5C), indicating PEG hydrogel’s capability of stromal cells and follicle 
driven remodeling. The density of blood vessels increased from 30 days post-Tx to 60 days post-
Tx (Fig.5.5D), further indicating to continuous remodeling and folliculogenesis. 
5.2.5. Graft longevity 
The ovarian reserve of follicles declines because of the non-renewable nature of the follicles. 
At the onset of menopause, ovarian reserve reaches about 5-10% of the initial number of 
follicular reserve, the levels of estradiol decrease and levels of FSH increase. Thus, we 
hypothesized that a positive correlation between the number of implanted follicles and the 
longevity of implanted graft exists. We investigated the longevity of PEG grafts with an average 
of 376 encapsulated follicles up to 90 days post-Tx. Physiological FSH levels (Fig.5.6A) and 
regular estrous cycles (Fig.5.6C) were maintained up to 70 days. Increasing FSH levels and more 
spread-out estrous cycles were observed beginning at 77 days, similar to premenopause. Multiple 
antral follicles and corpora lutea were presented in histological sections retrieved 90 days post 
transplantation (Fig.5.6D); however, all primordial follicles were exhausted by 90 days 
(Fig.5.6B), concluding the graft longevity. 
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5.3. Discussion 
In this study, we engineered a synthetic PEG hydrogel that supports implantation of isolated 
ovarian follicles and promotes ovarian function in vivo. Ovarian tissue from a blood borne cancer 
patient potentially could contain cancer cells and autotransplantation may lead to cancer 
recurrence. Our approach mitigates this problem because follicles are purified from the rest of 
the ovarian tissue by enzymatic tissue digestion. Several groups demonstrated that 
 
Figure 5.6 – Graft longevity: (A) FSH level that declined to physiological level increased beginning at 
70 days post-Tx due to follicle exhaustion within the graft. All data is reported as mean ± S.D. (nmice = 
6). An asterisks (*) denoted significance within the group transplanted with PEG graft compared to 
D60. Statistical significance was determined by a one-way ANOVA followed by Tukey’s test (p < 
0.01). (B) The total number of follicles declined over 90 days as a result of follicles entering growing 
pool, ovulate or undergoing atresia after activation. (C) Cyclicity was maintained up to 70 days, 
supporting 12 – 15 estrous cycles in all mice. However, reduced and irregular cycles were observed 
starting at 77 days post-Tx, which in agreement with the FSH levels. (nmice = 4) (D) Antral follicles 
and corpora lutea (CL) were still observed at 90 days post-Tx. 
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enzymatically-isolated follicles could be sorted from the rest of the ovarian tissue resided with 
cancer cells using microfluidic device(34) or by sedimentation(21). However, the survival and 
the function of enzymatically-harvested primordial follicles are low due to the lack of a structural 
support and cell signaling from the surrounding matrix(35, 36). Therefore, we employed PEG 
hydrogels with the storage modulus of 5.2kPa, which mimicked the stiffness of soft stromal 
tissues (Fig.5S2). And here we demonstrated that PEG hydrogels can provide the physical 
support to preserve oocyte-somatic cell connections and the overall architecture of encapsulated 
follicles while enabling follicular expansion through degradation. 
Volumetric expansion of the follicle is one of the key structural events during 
folliculogenesis. Starting at the primordial stage, the volumetric expansion of the growing 
follicle is approximately 300 folds in mice and about 10
5
 fold in humans when the follicle 
reaches antral preovulatory stages(15, 28). As a result, the surrounding matrix of the 
encapsulated follicles must accommodate the volumetric expansion associated with the follicular 
growth, either through elastic expansion or degradation. Natural hydrogels, such as alginate and 
fibrin, provided an important platform to study folliculogenesis in vitro and in vivo. For example, 
alginate hydrogels support follicle growth and 3D culture of rodent follicles. Yet, the non-
degradable nature of the alginate hydrogel was prohibitive in supporting the complete 
development of a human follicle, which typically reaches a diameter of 20 mm at the final 
stages(37). On the other hand, the fast degrading fibrin gels provided the required physical 
support for the remodeling and growth of the implanted follicles, but for a limited time(20). 
These examples emphasized the importance of material properties for the follicle growth and 
maturation. The synthetic tunable PEG hydrogels were able to accommodate massive volumetric 
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expansions of growing follicles within the graft as indicated by the presence of multiple fully-
grown antral follicles.  
We also observed the development of early-stage follicles into antral follicles and corpora 
lutea, concluding the final stage of folliculogenesis in PEG hydrogels after 30 days in vivo. The 
proportion of growing follicles continuously increased over the 60 days post implantation, while 
the total number of the follicles in the grafts decreased over the same period. The natural decline 
in follicle numbers occurs as immature follicles enter the growing pool every estrous cycle, then 
mature and ovulate. Maintaining high percentage of primordial and primary follicles after 60 
days in vivo suggested a selective activation, rather than a burst activation and premature 
depletion of primordial follicles, which is believed to be a common cause of an early graft 
failure(11-13). This resembles behavior of the normal ovarian reserve where the majority of 
primordial follicles remain in quiescent state and only a small cohort activates each cycle(37).  
Overall, multiple fully-grown antral follicles and the corpora lutea corresponded with the 
physiological levels of follicle-stimulating hormone (FSH). We measured the FSH levels to 
evaluate the function of the artificial ovarian tissue and the restoration of the endocrine 
hypothalamus-pituitary-gonad (HPG) axis. After the complete development of the early-stage 
follicles, granulosa cells of antral follicles produced high levels of estrogen, resulting in the 
restoration of feedback to reduce FSH secretion by the pituitary gland. We demonstrated that 
resumed cyclicity at 14 days, and significant decrease in FSH levels at 30 days post-Tx, which 
corresponded with the appearance of antral follicles in the histological sections. As the 
proportion of growing follicles continuously increased, FSH levels further declined reaching 
physiological levels, confirming the restoration of the HPG axis. Regular estrous cycles were 
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maintained up to 60 days, which is another indication of potential restoration of normal 
endocrine function. 
The described ovarian PEG graft initially sustained follicle survival by diffusion of essential 
nutrients without active vasculature(38). However, vascularization of the graft is needed to 
prevent hypoxia in the long-term, control follicular quiescence, and inhibit atresia for a larger 
construct with multiple growing follicles(39). Human ovarian cortical strips are dense and have 
longer revascularization periods, which negatively affect the outcomes of ovarian grafts(12, 13). 
Similarly, within plasma clots, oocytes were lost by extrusion and necrosis, and more losses 
occurred after transplantation due to hypoxia before the graft was vascularized(40). The presence 
of functioning blood vessels containing red blood cells shows a promising result of cell driven 
remodeling and tissue regeneration within PEG hydrogels. The formation of a vascular network 
occurred mostly around follicles due to the presence of high concentration of proangiogenic 
growth factors, such as vascular endothelial growth factor (VEGF)(41).  The presence of stromal 
cells is also likely to have contributed to vascularization process after grafting by regulating 
vascular remodeling and producing angiogenic factors(42). Neovascularization driven by 
endothelial and stromal cells of the host is a promising approach to reconstructing an artificial 
organ for long-term applications. These results demonstrate the promising role of synthetic PEG 
hydrogels as a platform for reproductive tissue engineering and regenerative medicine. 
 
5.4 Conclusion 
In summary, our study provides a systematic investigation of the first synthetic system for 
artificial ovarian tissue engraftment and regeneration.  PEG hydrogels with tunable mechanical 
properties and controlled degradation successfully supported folliculogenesis and steroidogenesis 
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in vivo. After 30 days, grafts revealed multiple fully developed antral follicles and corpora lutea, 
which corresponded with regular ovulation cycles and follicle-stimulating hormone (FSH) levels. 
The elevated levels of FSH, caused by bilateral ovariectomy, were reversed by the implanted 
follicles and maintained at physiological levels for 60 days. Importantly, primordial and primary 
follicles still represented 60% of the follicular pool, demonstrating selective recruitment of 
primordial follicles into the growing pool. Functioning blood vessels in the grafts 30 and 60 days 
after implantation proved the capability of PEG hydrogels to undergo graft remodeling and 
revascularization. Our results demonstrate for the first time that PEG hydrogels with 
encapsulated immature ovarian follicles successfully functioned as an artificial ovarian tissue for 
90 days in vivo. 
 
5.5 Materials and Methods 
5.5.1. Ovariectomy and orthotopic transplantation 
A bilateral ovariectomy (OvX) was performed on 12 – 16 week-old mice (B6CBAF1) to 
mimic premature ovarian failure and absence of ovarian endocrine function. Animals were 
treated in agreement with the NIH Guide for the Care and Use of Laboratory Animals and the 
Institutional Animal Care and Use Committee (IACUC) protocol at the University of Michigan. 
All the surgical procedures were approved and performed according to the IACUC protocol 
(PRO00006459). Ovaries were removed from the ovarian bursa as previously described(43) with 
some modification. Briefly, a 1.5cm longitudinal midline incision was made in the abdominal 
wall using aseptic techniques and procedures. Then intraperitoneal space was exposed with an 
abdomen retractor. Before the ovary was removed, the ovarian blood vessels were tied to prevent 
bleeding after ovariectomy. To prevent the bursal cavity from collapsing, a 15μL alginate (1.0% 
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w/v) bead was placed inside the bursal cavity and closed with 10-0 non-absorbable sutures 
(Fig.5.1A).  The same procedure was repeated for each ovary. The abdominal muscles and skin 
were closed with 5-0 absorbable sutures. Following recovery, the animal was housed in the 
animal facility for at least 14 days. Mice received analgesics for at least 48 hours after surgery or 
as needed. 14 – 21 days after ovariectomy, PEG hydrogels were transplanted into both orthotopic 
sites as described above, following removal of the alginate bead (Fig.5.1D-G). Ovariectomized 
mice were randomly assigned to a control group that did not receive PEG grafts post-OvX.  The 
graft function was assessed through daily vaginal cytology, serum levels of follicle-stimulating 
hormone (FSH), and histology of the retrieved PEG-VS hydrogels after 14 (nmice=11), 30 
(nmice=6), 60 days (nmice=6) and 90 days (nmice=4) after transplantation. Power analysis was 
performed using Graphpad StatMate (GraphPad Prism Software, La Jolla, CA) (alpha = 0.05, 
power > 80%) to determine the number of animals. 
5.5.2. Enzymatic follicle isolation and viability assessment 
For all experiments, ovaries were isolated from 6 – 7 day old female mice (B6CBA F1), 
separated from the connective tissues and enzymatically digested in 50μL (13 Wünsch units/mL) 
Liberase DH (Roche, Indianapolis, IN) in 500 μL L15 (Leibovitz’s) media (Sigma-Aldirch) 
(Fig.5.1B). The total digestion time was 50min at 37
o
C, followed by 20min gentle pipetting of 
enzyme-digested pieces. The enzyme digestion was arrested by adding 10% fetal bovine serum 
and the digest was transferred to a tube for sedimentation. The sedimentation velocity of 
primordial and primary follicles was calculated according to a previously published report(20). 
After 15min of sedimentation, the top half of the total media containing slower sinking arbitrary 
cells was removed. The rest of the media volume remaining follicular suspension was removed 
by centrifuging at 100G for 5min. To determine any deleterious effects of the isolation procedure 
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on the viability of enzymatically isolated follicles, double fluorescent labeling LIVE/DEAD Cell 
Imaging Kit (Invitrogen) was performed according to the manufacturer’s protocol. 
5.5.3 Encapsulation of enzymatically isolated follicles in PEG-VS hydrogels and graft 
preparation 
The hydrogels were prepared by dissolving 8 arm PEG-Vinyl sulfone (PEG-VS, 
hexaglycerol, 40,000 g mol
-1
, >99% purity, Jenkem Technology) in 0.05 M HEPES Buffer at pH 
7.66 at room temperature, followed by addition of integrin-binding peptide (RGD) (GenScript). 
The hydrogels were formed via Michael-type addition (MTA) chemistry with MMP-sensitive tri-
functional crosslinking peptides AcGCL↓GPAGCL↓GPACG (LGPA) (1217.45 g mol-1, >90% 
purity, GenScript, cleavage site indicated by ↓, cysteines with reactive thiols are in bold). The 
stoichiometric ratio of -VS to thiol (-SH) groups was kept at 1:1 ratio for all experiments. PEG 
hydrogels were modified with the integrin-binding peptide GCGYGRGDSPG (RGD) (1067.10 g 
mol
-1
, GenScript) to allow cell adhesion and migration. The modified PEG solution was kept at 
room temperature for 15min to allow the RGD peptide to chemically bind to the PEG precursor, 
and 6.5μL of the modified PEG solution was then pipetted into the concentrated follicle 
suspension and gently mixed. The LGPA crosslinker was dissolved in HEPES buffer and 5.5μL 
of the crosslinking peptide solution was added to the mixture of PEG-VS and follicle suspension. 
Two grafts with follicles (6.5μL each) were allowed to crosslink on a heating plate at 37 oC for 
10min to complete the MTA reaction. Upon complete gelation, these hydrogels were 
transplanted immediately into the ovarian bursa (Fig.5.1C). 
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5.5.4. Functionality of the artificial ovarian tissue 
5.5.4.1. Vaginal Cytology 
The presence of estrous cycle in the transplanted animals was determined by daily vaginal 
cytology. The animals were gently restrained by the tail and 0.1 – 0.2mL of saline was pushed 
using a syringe or a pipette in and out of the vaginal opening to collect cells to identify cycle 
stage every day, before and after transplantation. The onset and cessation of cyclicity were 
determined by the cell population in the vaginal lavage. 
5.5.4.2. Blood collection for measurements of follicle-stimulating hormone in serum  
Lateral tail vein blood (0.5-1% volume of the total body weight: ~ 0.075-0.15 mL from a 
mouse weighing 15 grams) was collected every 2 weeks to compare FSH levels pre- and post-
transplantation. The mouse was restrained in a mouse trap to allow easy access to the tail. The 
lower one half of the tail was cleaned with 70% alcohol and a small incision in the tail vein at the 
distal end of the tail was made using a sharp scalpel or razor blade. A new scalpel was used for 
each animal. 75 - 150μL blood was collected in a capillary tube and left at 4oC overnight to allow 
blood to clot. Then 10 - 20μL serum was aspirated from the sample following centrifugation at 
10,000rpm at 4
o
C for 10min and stored at -20
o
C.  At the terminal time point of the experiment, 
the blood was collected via cardiac puncture. All samples were labeled numerically to blind any 
correlation to time points or group assignments. The FSH levels were measured with 
Radioimmunoassay at Ligand Assay and Analysis Core Facility at University of Virginia Center 
for Research in Reproduction. 
5.5.5. Histological tissue analysis 
After 14 (nmice=11), 30 (nmice=6), 60 days (nmice=6) and 90 days (nmice=4) following 
transplantation, PEG-VS hydrogels were retrieved and fixed in Bouin’s fixative solution (Sigma-
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Aldrich) overnight, and then transferred to 70% EtOH at 4 
o
C until processing. The number of 
follicles and their distribution on day 0 (pre-transplantation) was characterized using HistoGel
TM
 
(Richard-Allan Scientific
TM
) using a similar procedure for encapsulation in PEG. After fixation, 
all samples were processed at the Histology Core in Microscopy & Image Analysis Laboratory at 
the University of Michigan. Samples were embedded in paraffin and serially sectioned at a 7μm 
thickness and were stained with hematoxylin and eosin (H&E) to identify and count follicles at 
all the developmental stages. Primordial follicles were identified by the nucleus, which is 
surrounded by a single layer of flattened squamous follicular cells. A primary follicle was 
defined as an oocyte surrounded by a single layer of cuboidal granulosa cells (GCs). A secondary 
follicle has two or more layers of cuboidal GCs, but no antrum, and the presence of a fluid-filled 
antrum defined an antral follicle. Extensive permeation of red blood cells into the ovulated 
follicle and luteinized granulosa cells were defined as corpora lutea (CL). 
Identified follicles were quantified by counting every-other section of every-other slide (4 
sections per slide) to prevent counting a follicle more than once(20). Since every-other slide was 
counted, a correction factor was applied to adjust for the counting rules. The oocyte diameter for 
primordial and primary follicles averaged 14µm (44), meaning the same follicle would appear 
only on 2 consecutive sections. Therefore, the numbers of primordial and primary follicles were 
doubled since every-other slides was counted. Primary, secondary, and antral follicles were 
counted when the nucleolus of the oocyte was present. This was done to prevent double counting 
of large growing follicles (secondary and antral) and undercounting smaller follicles.  
5.5.6. Immunohistochemistry 
 To analyze the neovascularization within transplanted PEG hydrogels, paraffin sectioned 
slides were stained for mouse endothelial cells. First, sections were deparaffinized with Xylene 
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and rehydrated in 100% Ethanol. Slides were incubated in 3% H2O2 for 30min at room 
temperature to block any endogenous peroxidase activity. Then, slides were incubated in 10mM 
Tris EDTA (pH 9) solution for 20min at 96
o
C and additional 20min at room temperature for 
antigen retrieval. Afterwards, non-specific bindings were blocked by the protein block (Abcam) 
for 1 hr followed by overnight incubation at 4
o
C with primary antibodies – rabbit anti-mouse 
CD34 antibody (1:500 dilution) (Abcam, catalog#ab81289) dissolved in TBS with 1% Normal 
Rabbit Serum (Sigma-Aldrich) and 0.1% Bovine Serum Albumin (Fisher Scientific). Following 
incubation overnight, slides were treated for 20min each with the Biotinylated Goat Anti-
Polyvalent and Streptavidin Peroxidase, provided in Rabbit Specific HRP/DAP Detection IHC 
Kit (Abcam). Hematoxylin was used for counterstaining. Healthy mouse uterus was used as 
positive control and negative control slides were incubated without the presence of primary 
antibody (Fig.5S3). The identical procedure was followed for both positive and negative control 
as described.  
5.5.7. Statistical Analysis 
All statistical analyses were performed using GraphPad Prism (GraphPad Prism Software, La 
Jolla, CA) and power analyses were performed using GraphPad StatMate (GraphPad Prism 
Software, La Jolla, CA) (alpha = 0.05, power >80%). Homogeneity of variance was determined 
with an F test. For sample sizes (n>5), data are reported as mean ± standard deviation of 
measurements, and statistical analyses were performed with one- way ANOVA followed by 
Tukey’s post-test.  And statistical significance was set at p<0.05. For sample sizes (n<5), 
individual data points were plotted and the statistical analyses were performed with the Kruskal-
Wallis test followed by Dunn’s post-test (Fig.5.3A), or Mann-Whitney test (Fig.5.5D).  
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CHAPTER VI 
 
 
 
Conclusion and Future Directions 
 
 
6.1  Conclusion 
 This work demonstrated the design of synthetic hydrogels to mimic the components of 
tissues that provide mechano-biological cues to reconstruct and regenerate the structure and their 
function in vivo. The extracellular matrix (ECM) provides the three-dimensional (3D) structure 
and paracrine signals that regulate and promote cell adhesion and directs the cellular processes 
leading to tissue development(1, 2). ECM also affects morphology(3), cell communication(4, 5), 
survival(6, 7), proliferation(8) and steroidogenesis(9). Naturally derived and synthetic hydrogels 
have been extensively exploited in biomedical materials research due to their abilities in 
directing cellular behavior and function(10, 11). These hydrogels have been used to examine 
cell-matrix interaction and have the potential to modify the components and density of ECM 
proteins. Different cellular responses result from interactions with specific integrins and adhesion 
sequences(12). Each chapter demonstrated the role of various material properties of 3D matrices 
on cellular behavior, morphology, and growth, which contributed to reconstruction and 
regeneration of a desired tissue. 
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In Chapter II, we addressed three different components toward building an artificial ovarian 
tissue, from enzymatic isolation and purification of the early stage follicles to encapsulation in 
natural hydrogels. Follicle sorting using microfluidic device would serve as future potential 
applications of clinical treatment-scale separation of ovarian follicles from cancer cells. After 
follicle isolation, multiple previous studies(13-16) confirmed that re-implanting of isolated 
follicles using fibrin hydrogels has shown promising results; however, the rapid degradation and 
coupled mechanical and biological properties of fibrin hydrogels resulted in early graft failure. 
This result further confirmed the importance of a precise control of hydrogel properties to design 
the optimum environment for long-term applications. 
In Chapter III, we explored the effect of mechanical properties of natural hydrogels like 
fibrin, fibrin-collagen, and collagen, on cellular growth and behavior. Fibrin degradation was 
controlled by using aprotinin to demonstrate the importance of a precise control of degradation 
rate. Throughout the different gel systems, more cell growth and more interconnected stromal 
network formation were observed when cells were in less rigid and more degradable 
environments, which allowed branching and cell remodeling. Unlike slow degrading collagen-
containing gel systems, fibrin degradation rate was controlled with aprotinin, which provided the 
structural support while allowing them to migrate and remodel their microenvironment. This 
result demonstrated how the defined control over degradation rate can balance matrix 
degradation and cell proliferation and regulate cellular behavior. 
As shown in Chapter III, natural hydrogels are compatible with live cells, support cell 
attachment, migration and remodeling; however, the mechanical and biological properties of 
these materials are closely tied. Supplementing the culture with aprotinin delayed fibrin 
degradation, yet for no longer than 10 days, limiting its long-term applications. In contrast to 
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natural hydrogels, biologically inert synthetic hydrogels, such as poly(ethylene glycol) (PEG), 
have tunable physical properties independent of their biological activity(17-22). Bioactive 
modification, such as incorporation of integrin binding sequences, affected the mechanical 
properties of multi-arm PEG gels, such as storage modulus and swelling, as a consequence of the 
macroscopic network changes. These changes were dependent on PEG functionality (4 vs. 8-
arm) and PEG solid concentrations, which are directly related to the concentration of elastically 
active chains and the overall amount of binding sites. 
Therefore, in Chapter IV, we explored the role of functionality and the effects of bioactive 
modification on the material properties of multi-arm PEG hydrogels. Overall, 8-arm PEG 
allowed a greater degree of modification and its macroscopic properties and crosslinking kinetics 
were less affected by the act of modification or quenching compared to 4-arm PEG. These 
advantages provide a finely tuned design for various biological applications with broad range of 
bioactive modification. And when human bone marrow stromal cells were encapsulated in 4 and 
8-arm PEG hydrogels, different cellular phenotype and behavior was observed from spheroids 
formation in 4-arm PEG to dense and connected stromal networks formation in 8-arm PEG. And 
different cellular phenotype and behavior was observed from spheroids formation in 4-arm PEG 
to dense and connected stromal networks formation in 8-arm PEG. These results demonstrate 
that bioactive modification not only affects the PEG hydrogel’s macroscopic properties, but also 
regulates cellular behavior. Overall, well-controlled biochemical and biophysical cues can mimic 
the complex components of ECM in synthetic hydrogels like PEG to function as a platform for 
diverse tissue engineering applications. 
Lastly, in Chapter V, we utilized synthetic PEG hydrogels as a supportive matrix for follicle 
development and neovascularization to initiate the graft remodeling in mice, functioning as an 
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artificial ovarian tissue. The mechanism and kinetics of degradation of the synthetic PEG matrix 
mirrored follicle growth and function in vivo. The degradation rate of the hydrogel and its 
physical properties provided the structural support for the implanted tissue, yet allowed follicle 
growth and expansion, and cell migration to maximize engraftment and revascularization of the 
matrix surrounding implanted mouse follicles. The graft function was supported by resumed 
cyclicity starting at 14 days post-Tx and the physiological levels of FSH were maintained up to 
84 days. In summary, this is the first study proving the concept of a fully functional artificial 
ovarian tissue transplant built on a platform of the synthetic PEG hydrogel. And this is also the 
first step towards a fully engineered synthetic hydrogel that will present a clinically translatable 
opportunity to preserve fertility and ovarian endocrine function in women with premature 
ovarian failure. 
 
6.2 Future directions 
Naturally derived and synthetic hydrogels have been extensively exploited in biomedical 
materials research as a platform for tissue engineering. There are many ongoing studies to 
understand the effect of biophysical and biochemical cues on cellular differentiation and 
function(23-25). However, there are still many mysteries to unfold to understand how each 
component in a complex set of tissues or organs play a role in regulating or maintaining the 
function. And PEG hydrogel can be utilized as a tool to unfold these mysteries by decoupling 
and isolating components of ECM and as a biomimetic platform for tissue engineering. 
In this dissertation, we showed the importance of the defined control over material properties 
and the effects on cellular behavior and tissue regeneration. We demonstrated 8-arm PEG 
allowed a greater degree of modification and its macroscopic properties; however, further studies 
 92 
 
will be needed to understand the effect of increasing functionality even more. The properties of 
star polymers are known to be affected steric hindrances(26); however, the threshold of 
functionality that results in complete gelation is still unknown. And plasmin-sensitive peptide 
YKNR and MMP-sensitive peptide LGPA were used in this study. However, bioactive 
modification with other protease sensitive peptide sequences and more than one peptide 
sequences at the same time can be investigated further, because different peptide sequences 
demonstrate different rate of degradation and specificity toward proteases(27). Other studies also 
have demonstrated the laminin-derived peptide YIGSR can be used in conjunction with 
fibronectin-derived RGD to enhance spreading on PEG gels(22, 28, 29). Further modification is 
possible by covalently bonding thiolated growth factors, which are incorporated into a PEG 
thiol-ene hydrogel promoting cell proliferation and matrix production(30). Incorporation of all of 
these components will allow better mimicking the complex system of tissue, which will further 
widen the scope of biomedical applications. 
The PEG graft initially sustained follicle survival by diffusion of essential nutrients without 
active vasculature(31). However, faster vascularization of the graft will need to happen to 
prevent hypoxia, control follicular quiescence, and inhibit atresia for a larger construct with 
multiple growing follicles. Human ovarian cortical strips are dense and have longer 
revascularization periods, which negatively affect the outcomes of ovarian grafts. To initiate 
vascularization and remodeling process in earlier stage after transplantation, growth factors, such 
as vascular endothelial growth factor (VEGF)(32), can be incorporated. Also neovascularization 
driven by endothelial and stromal cells of the host is a promising approach to reconstructing an 
artificial organ for long-term applications. 
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PEG hydrogels with tunable mechanical properties and controlled degradation successfully 
supported folliculogenesis and steroidogenesis in vivo in mice. However, this study is only the 
first step towards a fully engineered synthetic hydrogel that will present a clinically translatable 
opportunity to preserve fertility and ovarian endocrine function in women with premature 
ovarian failure. First of all, the restoration of fertility was not demonstrated in this dissertation, 
which determines the full restoration of both endocrine and reproductive function. However, the 
live-birth was demonstrated using fibrin as a graft material, suggesting the approach of grafting 
of isolated follicles can be a solution to fertility preservation(16). And in the context of clinical 
translation, there are still many hurdles to overcome. Human ovaries are not located within the 
ovarian bursa unlike those of mice, which would require different approach of transplantation. 
Also the number of follicles that determine the graft quality and longevity will be significantly 
affected by the quality of tissue from patients. 
 
6.3 Concluding Remarks 
To conclude, we demonstrated the structural reconstruction and functional regeneration of 
lymphoid and ovarian tissues using natural and synthetic hydrogel as a platform. By controlling 
the degradation rate of fibrin, we successfully reconstructed lymphoid stromal network in vitro. 
By characterizing and utilizing tunable multi-arm PEG hydrogels, we successfully regenerated 
an artificial ovarian tissue in vivo that restored the estrous cycle and HPG axis. However, as I 
stated before, this is only the first step toward a fully engineered artificial ovary. This research 
started with a strong motivation to improve the quality of human life, especially young women. 
My desire is that the information gathered in this dissertation will be a cornerstone to many other 
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researches that are intended to improve the quality of human life and eventually, relieve the pain 
of many suffering individuals. 
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Figure 3A1. Network density measurement using GFP fluorescence. A MATLAB code 
was created using the Image Processing Toolbox in order to determine the approximate area 
of fluorescent. Specifically, the green channel was parsed out from each image before using 
image segmentation functions to create a gradient picture. Image segmentation relies upon 
differences in contrast in order to create a binary mask of the image. The binary mask image 
contains outlines of the cells and the mask is dilated and filled in order to cover the full area 
of each cell. Within the binary mask, white spots are denoted as cells, thus determining the 
number of white pixels in each image and converting this number to a micron size results in a 
calculated cell area. Additionally, superimposing the binary mask outline onto the original 
image ensures that cell area was detected appropriately and performs an optional check. All 
images analyzed were taken by Leica DMI3000B at 100x magnification and images were 
screened, selected and analyzed a double-blind manner. 
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Figure 4A1. Computational modeling and simulation of 4 and 8-arm PEG hydrogels. 
(A) Model generation adapted from collagen model. Relative volume element (RVE) is 
10µm in size length and the number of random points generated for 4-arm PEG is 200 and 
100 for 8-arm PEG. Each arm length is set to 2µmwith crosslink threshold equal to 1µm. 
And total of four different models were simulated: 4-arm, 8-arm, 4-arm PEG blocked (one 
arm), and 8-arm PEG blocked (two arms). (B) Crosslinking density and (C) Shear modulus 
were simulated based on assumption of arm material property being 50MPa in elasticity and 
31nm in diameter with 10% shear loading. According to simulation, 8-arm PEG is stiffer 
than the 4-arm PEG and is less susceptible to the arm block, following the trend of 
experimental results. 
 100 
 
 
 
Figure 5S1 – Maximum cross-section area of PEG hydrogels. In order to analyze the PEG 
degradation, cross-section area measurements were taken from an H&E stained histological section 
of each sample. Each section at different time points was selected from the middle region of the 
entire sections. Measurements were performed using ImageJ 1.48v (U. S. National Institutes of 
Health, Bethesda, Maryland). PEG hydrogel implanted showed a bulk degradation behavior over 90 
days in vivo. Statistical significance was determined by a one-way ANOVA followed by Tukey’s test 
(p < 0.05). 
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Figure 5S2 - Storage modulus (G’) of 7% PEG-8VS (0.5mM RGD) crosslinked with LGPA: 
Frequency sweep test was performed at 10% strain to measure the storage modulus (G’) of 7% PEG-
8VS (0.5mM RGD) crosslinked with LGPA using AR-G2 rheometer (TA Instruments). These 
hydrogels were swollen in miliQ water for 24 hours before the measurement. 
 
 
 
Figure 5S3 - Healthy mouse uterus was used as positive control (A) and negative control (B) slides 
were incubated without the presence of primary antibody. Positive CD34 staining was only observed 
with the presence of primary antibody, confirming its specificity. Scale bar: 50 µm. 
 
